Malignant neoplasm of breast, HER-negative

C3_BREAST_ERNEG

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions not RX_ERPLUS	276281
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C50 Cause of death: ICD-9 — 174 Cause of death: ICD-8 — 174 Cancer registry: Topography ICD-O-3 — C50 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — [23] 2 out of 7 registries used, show all original rules.	8710
4. Check minimum number of events None	8710
5. Include endpoints None	8710
6. Filter based on genotype QC (FinnGen only)	8448

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE
Control conditions: not RX_ERPLUS

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF9

NAME	C3_BREAST_ERNEG
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!RX_ERPLUS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS	!RX_ERPLUS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C50
COD_ICD_9	174
COD_ICD_8	174
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C50
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	[23]

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of breast, HER-negative based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8448	8448	-
Unadjusted period prevalence (%)	3.00	3.00	-
Median age at first event (years)	58.23	58.23	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8700: Matched controls
85367

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

321.7

309

D70.82

ICD-10 Finland

Drug-induced neutropenia

25.4

317.5

225

TQB05

NOMESCO Finland

Puncture of skin of trunk

35.4

307.7

218

ZZF00

NOMESCO Finland

Graft of adipose tissue

37.4

307.7

263

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

307.7

3539

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

28.5

307.7

423

153

C50

ICD-10 Finland

Malignant neoplasm of breast

2080.1

307.7

1219

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

472.2

307.7

944

ZZR10

NOMESCO Finland

Flap of skin and muscle

101.5

307.7

290

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

80.3

307.7

262

5702

FHL

Local lymph node removal (eg armpit, groin)

86.8

307.7

182

X76

ICPC

Malignant neoplasm breast female

1282.3

307.7

720

HAC20

NOMESCO Finland

Total mastectomy

1320.9

307.7

2134

JN4BD

NOMESCO Finland

Extensive body CT

6.7

307.7

1015

1644

HAD99

NOMESCO Finland

Other plastic operation on breast

34.0

307.7

226

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

65.3

307.7

602

WF002

NOMESCO Finland

Radical radiotherapy

44.0

307.7

357

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

67.9

307.7

216

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

131.7

307.7

184

Z31.5

ICD-10 Finland

Genetic counselling

8.4

307.7

1017

1332

NK6AN

NOMESCO Finland

Total body bone isotope imaging

67.9

307.7

409

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

307.7

371

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

10.6

307.7

763

770

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

27.7

307.7

2557

1262

WX402

NOMESCO Finland

General anaesthesia

2.8

307.7

2103

8602

115

Kela drug reimbursment

Breast cancer

+∞

307.7

2828

HA1AA

NOMESCO Finland

X-ray mammography

26.1

307.7

3120

1790

A04AA02

ATC

granisetron; systemic, transdermal

422.2

307.7

1157

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

37.8

307.7

807

230

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

307.7

646

ZX090

NOMESCO Finland

Other technic of radiotherapy

529.3

307.7

649

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

853.2

307.7

335

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

37.8

307.7

229

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

137.3

307.7

801

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

307.7

498

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

307.7

385

XX3DW

NOMESCO Finland

Time consuming IT work

12.0

307.7

1851

1880

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

1900.5

307.7

683

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

1569.5

307.7

2506

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

96.7

307.7

1894

245

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

4264.8

307.7

1496

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

99.1

307.7

207

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

188.2

307.7

385

9703

FHL

Breast resection

14.5

307.7

363

255

HAB99

NOMESCO Finland

Other partial excision of mammary gland

31.0

307.7

1020

364

C50.99

ICD-10 Finland

Breast, unspecified

3735.0

307.7

1621

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

56.3

307.7

267

HAE99

NOMESCO Finland

Other reconstruction of breast

90.1

307.7

378

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

43.0

307.7

406

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

46.9

307.7

201

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

466.7

307.7

451

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

7.0

307.7

646

962

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

307.7

452

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

307.7

418

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

36.1

307.7

257

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

29.9

307.7

229

TQW20

NOMESCO Finland

Tatoe

213.3

307.7

569

A04AD12

ATC

aprepitant; systemic

721.3

307.7

487

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

307.7

607

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

5800.7

307.7

564

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

993.4

307.7

479

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

18.3

307.7

307

170

A03FA01

ATC

metoclopramide; systemic, rectal

5.7

307.7

3242

8016

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

307.7

1013

L02BG04

ATC

letrozole; oral

21.6

307.7

372

176

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

34.9

307.7

215

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

8.2

307.7

500

630

WX404

NOMESCO Finland

Intravenous generell anesthesy

4.0

307.7

2833

9287

L03AA13

ATC

pegfilgrastim; parenteral

3609.2

307.7

1012

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

642.3

307.7

1731

L03AA14

ATC

lipegfilgrastim; parenteral

3663.3

307.7

368

A04AA55

ATC

palonosetron, combinations; systemic

5133.7

307.7

956

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

528.5

307.7

694

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

680.0

307.7

2103

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

6.6

307.7

848

1366

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

329

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

307.7

805

H02AB02

ATC

dexamethasone; systemic

61.8

307.7

2347

507

WZC00

NOMESCO Finland

Treatment plan or consultation

3.1

307.7

3792

17210

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

92.2

307.7

369

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1807.5

307.7

808

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

320.6

307.7

405

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

307.7

3348

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

7069.1

307.7

676

A04AA01

ATC

ondansetron; systemic, rectal

7.8

307.7

1047

1469

L01BC06

ATC

capecitabine; oral

+∞

307.7

752

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

307.7

464

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

8669.4

307.7

813

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

67.1

307.7

342

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

307.7

1048

N63

ICD-10 Finland

Unspecified lump in breast

5.8

307.7

1463

2895

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

824.2

307.7

697

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

79.3

307.7

401

XX1XN

NOMESCO Finland

Other isotope examination

733.2

307.7

359

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2012.8

307.7

970

PJA12

NOMESCO Finland

Sentinel node biopsy

2972.6

307.7

4372

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

307.7

530

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

483.9

307.7

846

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

214.5

307.7

234

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

14192.7

307.7

1252

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

119.9

307.7

363

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

156.6

307.7

233

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

372

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

307.7

420

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

19.8

307.7

547

288

L03AA02

ATC

filgrastim; parenteral

120.1

307.7

375

ZX080

NOMESCO Finland

Image guided radiotherapy

2756.3

307.7

548

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

72.0

307.7

1280

204

WF003

NOMESCO Finland

Adjuvant radiotherapy

512.6

307.7

719

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

307.7

368

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

307.7

1020

HAB40

NOMESCO Finland

Wedge excision of mammary gland

219.2

307.7

3164

222

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

307.7

1403

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

6230.2

307.7

1599

WZC30

NOMESCO Finland

Teaching

3.1

304.0

1523

5510

JN4AD

NOMESCO Finland

Body CT examination

4.4

298.2

801

1912

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

295.5

284

WF049

NOMESCO Finland

Radiotherapy of metastasis

481.4

285.9

286

HAD40

NOMESCO Finland

Mastopexy

34.7

280.9

180

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

265.9

3627

20874

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

265.1

255

Z51.5

ICD-10 Finland

Palliative care

5.1

264.9

589

1202

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

74.0

257.6

141

ZX112

NOMESCO Finland

Subcutaneous

12.4

257.4

259

211

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

111.3

257.2

134

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.9

254.2

472

817

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

250.5

241

R4110

NOMESCO Finland

Physiotherapy

2.3

248.3

2819

14975

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

44.4

244.4

147

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

29.3

243.2

164

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

795.4

240.1

237

HA1HA

NOMESCO Finland

Tomosynthesis mammography

32.9

238.4

155

1CD02, ,

NOMESCO Finland

+∞

235.9

227

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

231.7

223

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

332.6

229.5

233

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

27.5

228.1

157

A79

ICPC

Malignancy NOS

68.6

223.9

124

L02BA01

ATC

tamoxifen; oral

323.7

223.3

227

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

54.5

218.7

126

HAC25

NOMESCO Finland

Radical mastectomy

+∞

212.9

205

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

210.8

203

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

206.6

199

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

24.2

205.4

148

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

35.0

203.5

130

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

201.4

194

WX702

NOMESCO Finland

Supraglottic ventilation device

3.7

200.6

689

1951

HA1SA

NOMESCO Finland

Expansion mammography

50.1

198.0

116

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

52.5

191.2

111

X21

ICPC

Breast sympt/compl female other

5.5

188.8

379

704

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

374.5

186.1

188

ZX120

NOMESCO Finland

Intravenous

3.1

185.5

843

2842

FM1FN

NOMESCO Finland

Heart function isotope examination

1830.1

178.4

174

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

176.4

2242

12174

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

175.4

169

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

174.3

168

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

170.2

164

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.9

168.5

519

1360

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

70.2

166.5

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

818.7

166.1

164

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

283.3

165.1

169

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

11.7

162.2

168

143

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

159.8

154

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.7

158.2

538

1509

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

157.7

152

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

156.6

151

9706

FHL

Ablation mammae, includes axillary exploration

+∞

155.6

150

Z51.0

ICD-10 Finland

Radiotherapy session

229.9

155.5

161

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

152.5

147

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.3

151.1

617

1945

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

258.5

150.7

155

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

173.2

147.9

156

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

147.3

142

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

1451.2

146.2

143

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

144.2

139

ZXA05

NOMESCO Finland

Left side

1.9

142.2

2500

15007

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

42.6

141.5

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

+∞

141.0

136

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

33.0

138.6

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

136.9

132

ZX070

NOMESCO Finland

Intensity modified radiotherapy

202.3

136.1

142

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

134.8

130

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

132.7

128

N64.9

ICD-10 Finland

Disorder of breast, unspecified

6.3

131.7

224

354

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

130.6

126

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

130.6

126

ZXA00

NOMESCO Finland

Right side

1.8

130.4

2621

16324

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

34.3

129.1

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

128.6

124

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

128.3

3500

23801

D05.0

ICD-10 Finland

Lobular carcinoma in situ

220.8

128.2

133

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

52.3

127.2

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

40.1

124.8

WF004

NOMESCO Finland

Palliative radiotherapy

313.2

124.8

127

HAA10

NOMESCO Finland

Biopsy of mammary gland

7.6

124.5

178

233

OAA41

NOMESCO Finland

Health check based on individual needs

67.2

122.1

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

246.9

120.3

124

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

120.2

116

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

120.2

116

128

Kela drug reimbursment

Cancers of female genital organs

306.1

119.6

122

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

118.2

114

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

6.7

117.0

189

283

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

298.2

116.6

119

JN4CD

NOMESCO Finland

Very extensive body CT

5.4

116.5

236

441

B01AB05

ATC

enoxaparin; parenteral

1.7

116.2

2817

18404

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

116.1

112

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

1092.1

112.0

110

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

1092.1

112.0

110

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

16.9

112.0

L01CA04

ATC

vinorelbine; systemic

+∞

111.9

108

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

111.9

108

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

110.9

107

HAD20

NOMESCO Finland

Liposuction of breast

36.4

110.7

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

10.6

109.8

121

113

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

108.8

105

1XC03, ,

NOMESCO Finland

529.6

107.2

107

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

105.7

102

ZZR00

NOMESCO Finland

Flap of skin

10.6

104.8

116

109

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

103.6

100

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

103.6

100

N02AA05

ATC

oxycodone; systemic

2.0

102.3

1381

7492

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.4

101.0

383

1149

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

981.5

100.6

9719

FHL

Other measure in this category

20.6

97.7

8500/2-C50.4

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast

+∞

97.4

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

117.0

97.4

106

HA1DA

NOMESCO Finland

Restricted mammography

37.7

97.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

97.2

3750

27301

D24

ICD-10 Finland

Benign neoplasm of breast

3.8

96.7

306

814

PJA10

NOMESCO Finland

Exploration of lymph nodes

10.5

95.5

106

100

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

95.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

95.3

WW500

NOMESCO Finland

Blood transfusion

4.2

95.2

262

630

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

921.2

94.4

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

94.3

X19

ICPC

Breast lump/mass female

4.4

90.1

230

522

1748X

ICD-9 Finland

Malignant neoplasm of female breast, Other specified sites of female breast

+∞

90.1

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

90.1

X26

ICPC

Fear of breast cancer female

7.5

90.1

130

172

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

35.2

89.2

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

51.3

88.9

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.6

88.1

214

467

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

88.0

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

88.0

ZXE00

NOMESCO Finland

One hour or less

1.6

87.6

3272

23467

8510/3-C50.9

ICD-O-3

Medullary carcinoma, NOS, of breast, NOS

+∞

86.0

HA1S1

NOMESCO Finland

Photography of breasts

40.2

85.8

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

103.6

85.4

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

103.6

85.4

B01AB10

ATC

tinzaparin; parenteral

2.2

85.1

781

3658

1745A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-outer quadrant

+∞

84.9

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

84.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

84.0

814

3896

TQW99

NOMESCO Finland

Other minor procedure on skin

2.9

82.9

406

1414

N64.5

ICD-10 Finland

Other signs and symptoms in breast

3.2

82.0

339

1071

QBJ00

NOMESCO Finland

Liposuction in trunk

9.2

81.7

100

108

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.2

81.1

219

519

N60.8

ICD-10 Finland

Other benign mammary dysplasias

8.9

79.4

100

112

JN6AD

NOMESCO Finland

CT of torso and neck

8.5

78.5

102

119

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

24.7

76.9

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.6

74.5

179

387

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

24.9

74.3

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.2

73.8

153

292

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

73.5

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

23.8

73.0

R50.9

ICD-10 Finland

Fever, unspecified

1.9

72.6

1028

5621

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

+∞

72.5

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.9

72.4

221

573

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

71.4

9702

FHL

Breast exploration and possible tumor removal

3.5

71.3

255

736

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

71.2

887

4645

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

71.0

965

5205

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

691.0

70.7

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

70.4

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

+∞

70.4

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

70.4

PJW99

NOMESCO Finland

Other operation on lymphatic system

348.6

70.2

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

24.7

69.8

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

3.2

69.2

276

853

WB610

NOMESCO Finland

Demanding neoadjuvant therapy of tumour with antibodies

+∞

68.3

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

338.6

68.1

XX1AD

NOMESCO Finland

Other CT-examination

104.6

67.4

9724

FHL

Breast augmentation or reconstruction with own tissue

28.4

67.4

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

22.4

67.3

N05CB02

ATC

barbiturates in combination with other drugs

2.6

67.2

402

1553

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.2

67.0

267

825

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

25.8

66.6

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

651.0

66.6

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

651.0

66.6

8140/3-C50.9

ICD-O-3

Adenocarcinoma, NOS, of breast, NOS

+∞

66.3

XX9TE

NOMESCO Finland

Compementary ultrasound examination

7.8

66.0

117

Z3231

NOMESCO Finland

Registered nurse

1.6

65.9

2117

14457

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

224.1

65.8

QBA00

NOMESCO Finland

Puncture of skin of trunk

10.8

65.2

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

65.2

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.0

63.1

185

466

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

62.1

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

18.3

61.7

HA1AE, ,

SPAT

2.9

61.4

297

1027

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

6.7

61.0

143

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

60.3

726

3748

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

304.0

59.9

HA1BA

NOMESCO Finland

Extensive X-ray mammography

7.6

59.2

109

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.4

58.7

439

1880

17409

ICD-8 Finland

Malignant neoplasm of breast, Unspecified

+∞

58.0

1743A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-inner quadrant

+∞

58.0

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

25.3

57.7

1741A

ICD-9 Finland

Malignant neoplasm of female breast, Central portion

+∞

56.9

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

7.9

56.5

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

55.9

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

9.0

55.5

C50.09

ICD-10 Finland

Malignant tumor of nipple and areola, other or undeterminated histology

+∞

54.9

S77

ICPC

Malignant neoplasm of skin

15.3

54.2

2393A

ICD-9 Finland

Neoplasm of unspecified nature, Breast

5.9

52.9

162

Z3226

NOMESCO Finland

Physiotherapist

1.6

52.7

1466

9615

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

262.4

51.8

ZSZ00

NOMESCO Finland

Primary repair operation

501.5

51.1

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

7.8

51.1

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

257.3

50.8

D05

ICD-10 Finland

Carcinoma in situ of breast

+∞

50.7

L02BG06

ATC

exemestane; oral

+∞

49.7

Z31.6

ICD-10 Finland

General counselling and advice on procreation

10.0

49.0

N62

ICD-10 Finland

Hypertrophy of breast

2.2

48.8

417

1889

N06AX16

ATC

venlafaxine; oral

1.6

48.4

1162

7339

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

241.8

47.7

8000/3-C50.9

ICD-O-3

Neoplasm, malignant of breast, NOS

+∞

47.6

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

+∞

47.6

C56

ICD-10 Finland

Malignant neoplasm of ovary

102.7

47.4

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.6

47.2

112

240

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

46.6

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

46.6

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

46.1

441

2088

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

46.0

634

3416

3AA13, ,

NOMESCO Finland

451.7

46.0

HAD00

NOMESCO Finland

Augmentation mammoplasty

59.2

45.9

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

231.8

45.7

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

45.5

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

84.0

45.5

N61

ICD-10 Finland

Inflammatory disorders of breast

3.0

45.5

211

713

WZC15, ,

NOMESCO Finland

17.0

45.3

N02BE01

ATC

paracetamol; systemic, rectal

1.6

45.0

7739

70880

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

44.7

311

1289

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

226.9

44.6

A02BC02

ATC

pantoprazole; systemic

1.4

44.4

5830

50564

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.5

43.9

8211/3-C50.9

ICD-O-3

Tubular adenocarcinoma of breast, NOS

+∞

43.5

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

15.6

43.4

S18

ICPC

Laceration/cut

1.4

42.6

3493

28012

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

79.0

42.5

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

42.4

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

41.8

3340

26650

WB321

NOMESCO Finland

Multiple adjuvant therapy of malignancy with biomodifiers

+∞

41.4

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.3

41.1

107

247

2330A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Breast

402.0

40.8

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.9

40.5

525

2770

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

40.4

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

9.7

40.0

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

11.2

39.5

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

39.3

JAL30

NOMESCO Finland

Omentectomy

5.3

38.8

145

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

38.7

1508

10569

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

4.9

38.4

172

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.3

38.4

285

1216

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

38.3

C50.0

ICD-10 Finland

Malignant neoplasm: Nipple and areola

+∞

38.3

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

38.3

156

Kela drug reimbursment

Lapatinib

+∞

38.3

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.3

38.0

221

9721

FHL

Mamilla reconstruction or transposition

55.5

38.0

J01MA12

ATC

levofloxacin; systemic

1.5

37.5

1259

8554

L02BG03

ATC

anastrozole; oral

131.4

37.4

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

37.2

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

37.2

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

7.3

36.8

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

362.1

36.7

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

6.0

36.3

105

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

36.2

SPAT1269

SPAT

Other puncture and/or drainage

6.3

36.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

35.8

469

2483

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

35.7

5455

47510

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

35.7

620

3579

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

35.4

249

1037

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

35.2

L57.0

ICD-10 Finland

Actinic keratosis

1.7

34.8

744

4544

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

46.0

34.3

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

46.0

34.3

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

11.9

34.2

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

34.1

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

34.1

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

33.8

389

1970

WF099

NOMESCO Finland

Other radiotherapy

9.2

33.6

DHB00

NOMESCO Finland

Excision of lesion of external nose

7.7

33.6

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

7.5

33.5

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.2

33.5

205

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

33.1

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

33.1

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

33.1

621

3661

B29

ICPC

Lymph/immune mech sympt/complt other

6.6

33.0

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.1

32.7

134

422

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

6.0

32.7

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

322.3

32.7

A04AA03

ATC

tropisetron; systemic

34.5

32.4

C90.0

ICD-10 Finland

Multiple myeloma

115.0

32.4

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

32.3

324

1562

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

32.1

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

+∞

32.1

L01XE07

ATC

[U] lapatinib

+∞

32.1

1740A

ICD-9 Finland

Malignant neoplasm of female breast, Nipple and areola

+∞

32.1

R18

ICD-10 Finland

Ascites

3.6

31.9

104

283

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.6

31.8

187

717

C20

ICD-10 Finland

Malignant neoplasm of rectum

312.4

31.6

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

31.0

8211/3-C50.4

ICD-O-3

Tubular adenocarcinoma of upper-outer quadrant of breast

+∞

31.0

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.7

30.9

167

613

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

30.9

161

580

XX2VW

NOMESCO Finland

Radiologic consultation

5.1

30.8

123

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

308.1

30.6

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

308.1

30.6

J01DB01

ATC

cefalexin; oral

1.4

30.4

6678

60480

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

30.3

202

822

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

30.0

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

30.0

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

30.0

XX2RW, ,

NOMESCO Finland

5.3

29.8

112

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

29.7

204

841

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.9

29.6

216

ZSZ10

NOMESCO Finland

Secondary repair operation

66.9

29.6

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.6

29.6

154

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

8.0

29.6

9708

FHL

Radical mastectomy (Halsted), also involves removal of the parasternal gland

297.8

29.6

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

297.8

29.6

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

29.4

572

3402

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

29.2

215

915

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

49.2

29.1

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

29.0

1XC13, ,

NOMESCO Finland

+∞

29.0

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

29.0

8500/2-C50.5

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast

+∞

29.0

XX2ET, ,

NOMESCO Finland

+∞

29.0

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

28.9

461

2592

N64.8

ICD-10 Finland

Other specified disorders of breast

4.2

28.8

178

ZX050

NOMESCO Finland

Stereotactic radiotherapy

10.9

28.7

9729

FHL

Other measure in this category

6.3

28.6

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

28.5

423

2328

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

28.5

129

431

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

6.3

28.2

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

28.2

167

643

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

8.3

28.0

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

27.9

580

8911

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

27.9

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

27.9

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

+∞

27.9

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

27.9

8500/2-C50.3

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast

+∞

27.9

WX400

NOMESCO Finland

Inhalation anesthesy

2.0

27.7

289

1414

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

3.8

27.6

214

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

28.0

27.3

HAB20

NOMESCO Finland

Excision of lactiferous duct

5.5

27.1

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

5.8

27.0

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

26.9

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

26.9

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

26.9

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

26.9

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

266.8

26.5

A46

ICD-10 Finland

Erysipelas

1.5

26.4

976

6728

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

137.8

26.4

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.6

26.4

151

572

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.1

26.3

110

351

TPX15

NOMESCO Finland

Removal of vascular injection port

9.5

26.1

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

25.9

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

25.9

C49.39

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor

+∞

25.9

C507, ,

ICD-10 Finland

+∞

25.9

8401/3-C50.9

ICD-O-3

Apocrine adenocarcinoma of breast, NOS

+∞

25.9

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

25.9

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

36.1

25.9

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.5

25.8

252

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.8

25.8

380

2086

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

5.2

25.8

101

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

6.8

25.6

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

256.5

25.5

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

256.5

25.5

Z2221

NOMESCO Finland

Medical doctor

1.3

25.3

1989

15565

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

25.3

5229

56137

WX704

NOMESCO Finland

Intubation

1.7

25.2

522

3157

KCD02

NOMESCO Finland

Transurethral resection of bladder

6.0

25.1

SPAT1324

SPAT

Screening procedure

0.7

25.1

879

12114

M05BA02

ATC

clodronic acid; systemic

27.9

25.1

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

7.7

24.9

ZQZ00

NOMESCO Finland

Treatment of several skin areas

7.7

24.9

8543/3-C50.9

ICD-O-3

Paget disease and intraductal carcinoma of breast of breast, NOS

+∞

24.8

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

24.8

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

+∞

24.8

8500/2-C50.2

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast

+∞

24.8

HA5CB

NOMESCO Finland

Galactography

6.2

24.6

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

246.2

24.5

A06AH03

ATC

naloxegol; oral

4.5

24.4

129

QBA10

NOMESCO Finland

Incision of skin of trunk

3.8

24.3

193

THA00

NOMESCO Finland

Needle biopsy of mamilla

8.5

23.9

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

23.8

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

23.8

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

23.8

8523/3-C50.9

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of breast, NOS

+∞

23.8

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

23.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

23.5

579

3652

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

45.9

23.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

22.8

523

3243

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

22.8

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

22.8

8575/3-C50.9

ICD-O-3

Metaplastic carcinoma, NOS, of breast, NOS

+∞

22.8

PJ5YQ, ,

NOMESCO Finland

+∞

22.8

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

22.8

C50.61

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, ductal tumor

+∞

22.8

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.5

22.4

218

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

118.1

22.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

22.4

522

3250

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

22.3

1362

10235

2170A

ICD-9 Finland

Benign neoplasm of breast[NEOPLASMA BENIGNUM MAMMAE]

3.3

22.3

252

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

22.2

188

850

HAD55

NOMESCO Finland

Incision of periprosthetic capsule of breast

51.2

21.9

N05CF01

ATC

zopiclone; oral

1.3

21.7

2697

22327

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.9

21.6

100

339

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

21.6

457

2779

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

216.4

21.4

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

21.4

138

555

M05BX04

ATC

denosumab; parenteral

1.6

20.9

533

3391

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

20.7

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

20.7

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

20.7

9020/3-C50.9

ICD-O-3

Phyllodes tumor, malignant of breast, NOS

+∞

20.7

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

20.7

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

20.7

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

20.7

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

20.7

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

59.0

20.7

X77

ICPC

Malignant neopl genital female other

36.6

20.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

20.5

770

5315

JFB30

NOMESCO Finland

Right hemicolectomy

4.3

20.4

119

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.4

20.4

111

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.7

20.4

107

389

ZXC96

NOMESCO Finland

Robot assisted procedure

3.4

20.2

204

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

20.2

243

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

19.7

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

19.7

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

19.7

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

19.7

335

Kela drug reimbursment

Lapatinib

+∞

19.7

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

19.7

L01CB01

ATC

etoposide; systemic

+∞

19.7

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

196.7

19.4

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

196.7

19.4

QWF00

NOMESCO Finland

Reoperation for insufficiency of suture in plastic surgery of skin

196.7

19.4

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

103.3

19.4

HA1DM

NOMESCO Finland

Mammary gland very extensive MRI examination with 3 Tesla magnet

39.3

19.3

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

19.3

639

4302

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

19.2

265

1427

HA1AT, ,

SPAT

7.6

19.1

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

30.7

19.0

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

25.6

18.9

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.3

18.8

139

595

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

18.6

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

18.6

8401/3-C50.4

ICD-O-3

Apocrine adenocarcinoma of upper-outer quadrant of breast

+∞

18.6

8211/3-C50.2

ICD-O-3

Tubular adenocarcinoma of upper-inner quadrant of breast

+∞

18.6

8530/3-C50.9

ICD-O-3

Inflammatory carcinoma of breast, NOS

+∞

18.6

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

18.6

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

6.8

18.6

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

68.7

18.5

X79

ICPC

Benign neoplasm breast female

16.8

18.4

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

186.8

18.4

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

186.8

18.4

A08

ICPC

Swelling

1.6

18.3

415

2568

JAL00

NOMESCO Finland

Biopsy of peritoneum

5.3

18.0

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.3

17.9

201

A21

ICPC

Risk factor for malignancy

26.2

17.6

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

17.6

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

17.6

8522/3-C50.4

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast

+∞

17.6

8523/3-C50.4

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast

+∞

17.6

8480/3-C50.4

ICD-O-3

Mucinous adenocarcinoma of upper-outer quadrant of breast

+∞

17.6

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

17.6

WW200, ,

SPAT

0.8

17.5

1211

15048

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.2

17.5

214

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

177.0

17.4

HAF00

NOMESCO Finland

Excision of local recurrence of breast cancer

177.0

17.4

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

2.1

17.2

153

707

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.4

17.2

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.9

17.1

231

1237

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.4

17.0

121

509

X18

ICPC

Breast pain female

2.2

17.0

146

665

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.0

17.0

254

L02AE02

ATC

leuprorelin; implant, parenteral

3.1

16.8

219

B01AB04

ATC

dalteparin; parenteral

1.7

16.8

339

2037

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

16.5

L04AX04

ATC

lenalidomide; oral

+∞

16.5

8520/3-C50.5

ICD-O-3

Lobular carcinoma, NOS, of lower-outer quadrant of breast

+∞

16.5

8575/3-C50.4

ICD-O-3

Metaplastic carcinoma, NOS, of upper-outer quadrant of breast

+∞

16.5

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

16.5

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

16.5

1511

Kela drug reimbursment

Olaparib

+∞

16.5

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

16.5

389

Kela drug reimbursment

Olaparib

+∞

16.5

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

16.5

ZZS50

NOMESCO Finland

Insertion of tissue expander

88.6

16.4

ZXC90

NOMESCO Finland

Use of absorbable mesh in surgery

88.6

16.4

ZZS55

NOMESCO Finland

Distension of tissue expander

88.6

16.4

153

Kela drug reimbursment

Lenalidomid

167.1

16.4

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

167.1

16.4

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

167.1

16.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

167.1

16.4

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

167.1

16.4

R84

ICPC

Malignant neoplasm bronchus/lung

39.3

16.2

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

16.1

368

2282

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

15.7

615

4274

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

32.8

15.6

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

32.8

15.6

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

15.5

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

15.5

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

15.5

8510/3-C50.4

ICD-O-3

Medullary carcinoma, NOS, of upper-outer quadrant of breast

+∞

15.5

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

15.5

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

15.5

8500/2-C50.1

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast

+∞

15.5

L02AB02

ATC

medroxyprogesterone; systemic

3.6

15.5

141

N02AA01

ATC

morphine; systemic, rectal

2.7

15.5

306

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

157.3

15.4

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

15.3

176

894

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

15.3

330

2018

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

2.6

15.2

314

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.0

15.2

165

822

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.2

15.2

131

599

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

15.1

140

659

103

Kela drug reimbursment

Diabetes, insulin-treated

0.8

15.0

1258

15282

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

44.2

14.9

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

44.2

14.9

GA5AA

NOMESCO Finland

Rib X-ray examination

5.1

14.9

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.9

14.8

236

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.6

14.7

336

5081

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.3

14.7

108

462

SPAT1153

SPAT

Removal of sutures

1.2

14.7

2236

18759

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

6.4

14.5

L01AX03

ATC

temozolomide; systemic

+∞

14.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

14.5

1CD01, ,

NOMESCO Finland

+∞

14.5

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

14.5

8504/2-C50.9

ICD-O-3

Encapsulated papillary carcinoma of breast, NOS

+∞

14.5

C50.02

ICD-10 Finland

Malignant tumor of nipple and areola, lobular tumor

+∞

14.5

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

14.5

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

14.5

L01XK01

ATC

olaparib; oral

+∞

14.5

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

14.5

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

14.5

9680/3-C50.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of breast, NOS

+∞

14.5

1744A, ,

ICD-10 Finland

+∞

14.5

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

14.5

1XC14, ,

NOMESCO Finland

+∞

14.5

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

14.5

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.8

14.5

1118

13734

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

78.7

14.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

78.7

14.4

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.5

14.4

370

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

147.4

14.3

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

147.4

14.3

HAC99

NOMESCO Finland

Other mastectomy

147.4

14.3

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

147.4

14.3

D75

ICPC

Malignant neoplasm colon/rectum

12.3

14.2

HAB30

NOMESCO Finland

Excision of mamilla or areola

16.6

14.1

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

11.1

14.1

JFF23

NOMESCO Finland

Transversostomy

4.6

14.0

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

41.7

14.0

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

17.2

13.7

A10BA02

ATC

metformin; oral

0.8

13.6

1386

16478

N05BA04

ATC

oxazepam; oral

1.2

13.6

2084

17472

E0000UV, ,

ATC

1.2

13.6

3192

27873

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

13.5

260

1544

9722

FHL

Reduction plastic and possible mamilla transposition

3.8

13.5

103

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

73.8

13.5

8520/3-C50.1

ICD-O-3

Lobular carcinoma, NOS, of central portion of breast

+∞

13.4

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

13.4

8097/3-C44.3

ICD-O-3

Basal cell carcinoma, nodular of skin of other and unspecified parts of face

+∞

13.4

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

13.4

C49.30

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax without histology

+∞

13.4

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

13.4

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

13.4

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

13.4

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

13.4

4365

46453

GDC00

NOMESCO Finland

Lobectomy of lung

17.9

13.2

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.1

13.2

172

ZZA00

NOMESCO Finland

Split skin graft

2.0

13.0

131

637

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

4.2

13.0

QCJ00

NOMESCO Finland

Liposuction in upper limb

18.7

12.7

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

49.1

12.7

A87

ICPC

Complication of medical treatment

3.0

12.7

181

JAH00

NOMESCO Finland

Laparotomy

2.0

12.6

131

645

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.7

12.5

242

N05BA06

ATC

lorazepam; systemic, sublingual

1.5

12.5

341

2204

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.6

12.5

304

1915

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

12.5

1525

12469

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

68.7

12.5

ZSP00

NOMESCO Finland

Procedure related to previous procedure classified in chapter P

31.5

12.4

D77

ICPC

Malignant digestive neopl other/NOS

31.5

12.4

8500/2-C50.8

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast

+∞

12.4

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

12.4

Z44.3

ICD-10 Finland

Fitting and adjustment of external breast prosthesis

+∞

12.4

1501

Kela drug reimbursment

Palbociclib

+∞

12.4

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

12.4

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

12.4

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

12.4

394

Kela drug reimbursment

Palbociclib

+∞

12.4

8543/3-C50.1

ICD-O-3

Paget disease and intraductal carcinoma of breast of central portion of breast

+∞

12.4

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

12.4

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

12.4

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

+∞

12.4

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

12.4

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

12.4

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

12.4

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

12.4

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

12.4

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

12.4

8520/3-C50.8

ICD-O-3

Lobular carcinoma, NOS, of overlapping lesion of breast

+∞

12.4

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

12.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

12.4

113

530

HAD57

NOMESCO Finland

Resection of periprosthetic capsule of breast

17.0

12.4

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

127.8

12.3

329

Kela drug reimbursment

Lenalidomide

127.8

12.3

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

10.8

12.3

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

23.9

12.3

ZXC82

NOMESCO Finland

Microsurgical

19.7

12.3

T90

ICPC

Diabetes non-insulin dependent

0.8

12.1

1138

13684

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

12.1

839

6392

QBJ99

NOMESCO Finland

Other aesthetic correction of skin of trunk

15.6

12.0

N60.0

ICD-10 Finland

Solitary cyst of breast

2.7

11.9

226

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

11.9

1495

12255

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

9.8

11.8

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

4.7

11.8

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.5

11.6

287

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

4.7

11.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

11.6

473

3316

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.8

11.5

1153

13770

JG1BG

NOMESCO Finland

MRI of rectum

12.3

11.5

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.6

11.4

254

JFF10

NOMESCO Finland

Loop enterostomy

5.0

11.4

LE090

NOMESCO Finland

Profylactive radiotherapy of vulva and vagina

+∞

11.4

ZZQ60

NOMESCO Finland

Free microvascular graft of nerve

+∞

11.4

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

11.4

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

11.4

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

11.4

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

11.4

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

11.4

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

11.4

8522/3-C50.5

ICD-O-3

Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast

+∞

11.4

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

11.4

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

11.4

8540/3-C50.0

ICD-O-3

Paget disease, mammary of nipple

+∞

11.4

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

11.4

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

11.4

C739, ,

ICD-10 Finland

+∞

11.4

C50.69

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, other or undeterminated histology

+∞

11.4

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

11.4

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

11.4

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

11.4

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

117.9

11.3

9710

FHL

Existence of a relapse

117.9

11.3

ZZA50

NOMESCO Finland

Full thickness skin graft

9.0

11.3

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.1

11.3

100

464

SAA01

NOMESCO Finland

Simple examination of mouth

0.9

11.3

4839

50743

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

11.2

1138

9104

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

34.4

11.1

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

34.4

11.1

A26

ICPC

Fear of cancer, NOS

3.0

11.1

153

G03FA01

ATC

norethisterone and estrogen; systemic

0.8

11.1

1149

13670

ZX121

NOMESCO Finland

Central venous catheter

9.4

11.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

11.0

634

4703

9734

FHL

Excision and local plastic or associated free skin grafting

3.1

10.8

145

ZZR70

NOMESCO Finland

Perforator flaps

42.5

10.8

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

10.8

1388

11395

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.7

10.7

301

4360

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.7

10.6

565

7328

E66.01

ICD-10 Finland

Obesity due to excess calories

0.7

10.6

294

4267

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

58.9

10.5

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

10.5

292

1897

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.2

10.4

123

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

5.5

10.4

SPAT1152

SPAT

Removal of foreign body from under the skin

1.7

10.4

174

999

8524/3-C50.9

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of breast, NOS

+∞

10.3

L01EH01

ATC

lapatinib; oral

+∞

10.3

1BC02, ,

NOMESCO Finland

+∞

10.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

10.3

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

+∞

10.3

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

10.3

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

10.3

9120/3-C50.9

ICD-O-3

Hemangiosarcoma of breast, NOS

+∞

10.3

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

10.3

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

+∞

10.3

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

10.3

8509/2-C50.9

ICD-O-3

Solid papillary carcinoma in situ of breast, NOS

+∞

10.3

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

10.3

8520/3-C50.3

ICD-O-3

Lobular carcinoma, NOS, of lower-inner quadrant of breast

+∞

10.3

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

10.3

8503/2-C50.4

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of upper-outer quadrant of breast

+∞

10.3

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

10.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

10.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

10.3

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

10.3

9829

FHL

Other measure in this category

108.1

10.3

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

108.1

10.3

ZXD05

NOMESCO Finland

Urgent procedure

1.2

10.3

1875

15924

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

10.2

2052

17574

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

10.2

450

3198

A14AB01

ATC

nandrolone; parenteral

4.4

10.2

SAA02

NOMESCO Finland

Basic examination of mouth

0.9

10.2

4331

45630

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

10.1

420

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.0

10.1

102

499

ZXA10

NOMESCO Finland

Bilateral

1.2

10.0

1447

12020

C44

ICD-10 Finland

Other malignant neoplasms of skin

8.3

9.9

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

39.3

9.9

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.5

9.8

310

2071

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.5

9.7

296

1963

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.4

9.7

275

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.1

9.6

402

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

9.6

171

1000

-1, ,

ICD-10 Finland

1.6

9.5

239

1519

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

9.5

7241

68661

L02AE03

ATC

goserelin; implant

2.8

9.4

168

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

3.4

9.4

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

14.7

9.4

2506

FHL

Thyroidectomy

5.2

9.4

N81.1

ICD-10 Finland

Cystocele

0.7

9.4

493

6405

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

98.3

9.3

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

98.3

9.3

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

98.3

9.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

98.3

9.3

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

98.3

9.3

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

9.3

205

1264

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

9.3

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

+∞

9.3

C51.81

ICD-10 Finland

Squamous cell carcinoma of the vulva

+∞

9.3

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

9.3

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

9.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

9.3

8097/3-C44.5

ICD-O-3

Basal cell carcinoma, nodular of skin of trunk

+∞

9.3

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

9.3

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

+∞

9.3

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

+∞

9.3

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

+∞

9.3

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

9.3

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

9.3

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

9.3

JJB10

NOMESCO Finland

Atypcal resection of liver

21.3

9.2

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.1

9.2

117

ZXM40

NOMESCO Finland

Use of fluorescent substance

10.4

9.1

XX9XW, ,

NOMESCO Finland

3.2

9.1

103

9705

FHL

Subcutaneous mastectomy

13.4

9.1

ZXD20

NOMESCO Finland

Day surgery

1.3

9.0

912

7291

R06AE07

ATC

cetirizine; oral

1.2

8.9

3511

31616

E34.0

ICD-10 Finland

Carcinoid syndrome

36.0

8.9

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

3.7

8.9

SFA20

NOMESCO Finland

Two-surface restoration

0.9

8.9

3673

38951

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

2.8

8.9

157

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.1

8.8

402

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

4.9

8.8

PD2BD

NOMESCO Finland

Extensive CT angiography of pelvic organs

18.2

8.8

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

23.6

8.8

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

3.0

8.8

126

SFA10

NOMESCO Finland

One-surface restoration

0.9

8.7

3421

36426

KAC10

NOMESCO Finland

Total nephrectomy with capsule

7.8

8.7

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

9.3

8.6

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.7

8.6

152

887

X20

ICPC

Nipple symptom/complaint female

3.4

8.6

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

49.1

8.6

WX707

NOMESCO Finland

Fiberoscopic intubation

4.8

8.6

EBA00

NOMESCO Finland

Extraction of tooth

0.8

8.6

1815

20237

K02.1

ICD-10 Finland

Caries of dentine

0.9

8.6

3525

37428

TJF80

NOMESCO Finland

Ostomy education

3.2

8.6

102

L91.0

ICD-10 Finland

Hypertrophic scar

2.2

8.6

310

J05AB11

ATC

valaciclovir; oral

1.2

8.5

1040

8479

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.6

8.5

178

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

1.9

8.5

510

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

3.0

8.5

118

N81.6

ICD-10 Finland

Rectocele

0.8

8.5

495

6336

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

16.0

8.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

27.0

8.4

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

27.0

8.4

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

27.0

8.4

D76

ICPC

Malignant neoplasm pancreas

88.5

8.3

9822

FHL

Myocutaneous graft

88.5

8.3

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

88.5

8.3

HA1DT

NOMESCO Finland

Mammary gland biopsy with MRI guidance

88.5

8.3

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

88.5

8.3

189

Kela drug reimbursment

Imatinib

88.5

8.3

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

88.5

8.3

9844

FHL

Musculocutaneous tongue

88.5

8.3

PJW20

NOMESCO Finland

Lymphovenous shunt

88.5

8.3

L04AX03

ATC

methotrexate; systemic

0.7

8.3

467

6014

A98

ICPC

Health maint/preventive medicine

0.8

8.3

7909

79094

Z2446

NOMESCO Finland

Social worker

1.4

8.3

312

2157

1DB03, ,

NOMESCO Finland

+∞

8.3

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

8.3

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

+∞

8.3

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

8.3

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

8.3

1746A

ICD-9 Finland

Malignant neoplasm of female breast, Axillary tail

+∞

8.3

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

+∞

8.3

8522/3-C50.2

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast

+∞

8.3

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

+∞

8.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

8.3

C80.9

ICD-10 Finland

Malignant neoplasm, primary site unspecified

+∞

8.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

8.3

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

8.3

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

+∞

8.3

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

+∞

8.3

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

8.3

C49.19

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor

+∞

8.3

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

8.3

8211/3-C50.5

ICD-O-3

Tubular adenocarcinoma of lower-outer quadrant of breast

+∞

8.3

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

8.3

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

8.3

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

8.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

8.3

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

8.3

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

8.3

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

8.3

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

8.3

8010/3-C50.4

ICD-O-3

Carcinoma, NOS, of upper-outer quadrant of breast

+∞

8.3

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

8.3

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

8.3

8501/2-C50.9

ICD-O-3

Comedocarcinoma, noninfiltrating of breast, NOS

+∞

8.3

L01XE01

ATC

[U] imatinib

+∞

8.3

8503/3-C50.9

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of breast, NOS

+∞

8.3

8541/3-C50.9

ICD-O-3

Paget disease and infiltrating duct carcinoma of breast of breast, NOS

+∞

8.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

8.3

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

8.3

283

1923

XX9KE

NOMESCO Finland

Ultrasound examination with contrast

12.5

8.3

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

4.0

8.3

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

3.0

8.2

110

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

10.5

8.2

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

10.5

8.2

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

0.9

8.2

2880

30936

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.6

8.1

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

6.9

8.1

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

32.7

8.0

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.8

8.0

783

9396

NK6SN

NOMESCO Finland

Bone SPECT

21.6

7.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.3

7.9

460

3421

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

3.8

7.9

WPA13

NOMESCO Finland

Palliative consultation

4.4

7.9

P20

ICPC

Memory disturbance

0.8

7.8

770

9240

N02AX02

ATC

tramadol; systemic, rectal

1.1

7.8

3061

27494

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.6

7.7

L03

ICPC

Low back symptom/complaint

0.9

7.7

1721

19138

A07AA02

ATC

nystatin; oral

1.3

7.7

444

3296

C10AA07

ATC

rosuvastatin; oral

0.9

7.6

2050

22479

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

44.2

7.6

HAA01

NOMESCO Finland

Suture of mammary gland

44.2

7.6

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

1.8

7.6

523

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

3.4

7.6

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

18.0

7.5

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

18.0

7.5

PJD99

NOMESCO Finland

Excision of other lymph nodes

24.5

7.5

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

1.5

7.5

244

1645

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

7.4

924

7552

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

78.7

7.4

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

78.7

7.4

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

78.7

7.4

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.5

7.3

192

1236

6101A

ICD-9 Finland

Benign mammary dysplasias, Diffuse cystic mastopathy

2.4

7.3

204

TQX05

NOMESCO Finland

Skin puncture, unspecified location

4.0

7.3

HAD35

NOMESCO Finland

Reduction mammoplasty with transplantation of areola

4.0

7.3

J01FF01

ATC

clindamycin; systemic

1.2

7.3

1835

15951

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

7.3

3642

33179

A10AE04

ATC

insulin glargine; parenteral

0.7

7.3

291

3944

WZC00, ,

SPAT

0.8

7.2

408

5249

8201/3-C50.9

ICD-O-3

Cribriform carcinoma, NOS, of breast, NOS

+∞

7.2

8507/3-C50.4

ICD-O-3

Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast

+∞

7.2

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

7.2

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

7.2

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

7.2

8503/3-C50.4

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of upper-outer quadrant of breast

+∞

7.2

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

7.2

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

7.2

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

7.2

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

7.2

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

7.2

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

+∞

7.2

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

7.2

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

7.2

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

7.2

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

+∞

7.2

18301

ICD-8 Finland

Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary

+∞

7.2

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

7.2

4CJ01, ,

NOMESCO Finland

+∞

7.2

C54.12

ICD-10 Finland

Adenosquamous carcinoma of the endometrium

+∞

7.2

1XC07, ,

NOMESCO Finland

+∞

7.2

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

7.2

8520/2-C50.4

ICD-O-3

Lobular carcinoma in situ, NOS, of upper-outer quadrant of breast

+∞

7.2

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

+∞

7.2

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

7.2

8200/3-C50.9

ICD-O-3

Adenoid cystic carcinoma of breast, NOS

+∞

7.2

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

7.2

WC402

NOMESCO Finland

Demanding antibody therapy of local recurrence of tumour

+∞

7.2

L01BC59

ATC

trifluridine, combinations; systemic

+∞

7.2

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.2

7.2

261

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.4

7.2

272

1885

L88

ICPC

Rheumatoid/seropositive arthritis

0.7

7.1

173

2574

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

7.1

455

5751

WPB10

NOMESCO Finland

Making a convalescent care decision

6.1

7.1

WZC30, ,

SPAT

0.7

7.1

208

2978

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.1

7.1

302

XX9CN, ,

NOMESCO Finland

29.5

7.1

WE198

NOMESCO Finland

Palliative cystotatic therapy

29.5

7.1

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.8

7.1

106

593

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.9

7.0

1466

16404

G03DA02

ATC

medroxyprogesterone; systemic

1.2

7.0

970

8005

C10AA01

ATC

simvastatin; oral

0.9

6.9

2767

29575

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

1.6

6.9

159

996

ZX122

NOMESCO Finland

Intra-arterial

4.0

6.9

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.3

6.9

204

KMAK, ,

NOMESCO Finland

0.9

6.9

3155

33429

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.2

6.8

681

5432

QX4YT

NOMESCO Finland

Puncture of superficial collection under ultrasound guidance

3.5

6.8

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.8

6.8

693

8282

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

2.7

6.7

129

H01CB02

ATC

octreotide; parenteral

8.1

6.7

WE100

NOMESCO Finland

Profylactic cytostatic therapy

39.2

6.7

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

6.6

1010

11611

HAA00

NOMESCO Finland

Incision of mammary gland

6.0

6.6

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.0

6.6

L58.9

ICD-10 Finland

Radiodermatitis, unspecified

22.1

6.6

A07AA09

ATC

vancomycin; oral

1.8

6.6

476

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

6.6

114

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

0.7

6.6

254

3460

205

Kela drug reimbursment

Chronic hypertension

0.9

6.6

1528

16960

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.9

6.5

1550

17181

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.2

6.5

215

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.7

6.5

218

3042

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.7

6.5

121

720

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.1

6.4

274

S04

ICPC

Lump/swelling localized

1.2

6.4

639

5097

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

1.6

6.4

124

745

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.7

6.4

101

575

WX600

NOMESCO Finland

Single shot through catheter

2.1

6.4

275

ZXC50

NOMESCO Finland

Cryotherapy

1.6

6.4

137

845

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

68.6

6.4

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

68.6

6.4

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

68.6

6.4

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

68.6

6.4

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

68.6

6.4

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

68.6

6.4

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

68.6

6.4

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

68.6

6.4

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

68.6

6.4

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

3.4

6.3

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

3.4

6.3

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

5.6

6.3

OAB42, ,

SPAT

0.8

6.3

396

5017

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.2

6.3

212

SPAT1310

SPAT

Counselling related to known health issue

0.9

6.3

1909

20804

C10AX09

ATC

ezetimibe; oral

0.8

6.3

760

8927

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.9

6.3

1745

19128

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

6.4

6.2

C43

ICD-10 Finland

Malignant melanoma of skin

10.8

6.2

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

6.2

174

1140

9691/3-C42.1

ICD-O-3

Follicular lymphoma, grade 2 of bone marrow

+∞

6.2

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

6.2

8480/3-C50.2

ICD-O-3

Mucinous adenocarcinoma of upper-inner quadrant of breast

+∞

6.2

176

Kela drug reimbursment

Regorafenib

+∞

6.2

8480/3-C50.1

ICD-O-3

Mucinous adenocarcinoma of central portion of breast

+∞

6.2

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

+∞

6.2

369

Kela drug reimbursment

Regorafenib

+∞

6.2

8010/2-C50.9

ICD-O-3

Carcinoma in situ, NOS, of breast, NOS

+∞

6.2

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

6.2

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

6.2

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

6.2

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

6.2

3009

Kela drug reimbursment

Niraparib

+∞

6.2

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

6.2

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

+∞

6.2

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

6.2

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

+∞

6.2

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

6.2

1512

Kela drug reimbursment

Ibrutinib

+∞

6.2

17401

ICD-8 Finland

Malignant neoplasm of breast, Cutis

+∞

6.2

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

6.2

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

6.2

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

+∞

6.2

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

6.2

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

6.2

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

6.2

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

6.2

C49.38

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the chest Ewing's sarcoma

+∞

6.2

185

Kela drug reimbursment

docetaxel

+∞

6.2

390

Kela drug reimbursment

Ibrutinib

+∞

6.2

8201/3-C50.4

ICD-O-3

Cribriform carcinoma, NOS, of upper-outer quadrant of breast

+∞

6.2

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

6.2

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

6.2

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

6.2

C49.3

ICD-10 Finland

Malignant neoplasm: Connective and soft tissue of thorax

+∞

6.2

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

6.2

8480/3-C50.3

ICD-O-3

Mucinous adenocarcinoma of lower-inner quadrant of breast

+∞

6.2

9699/3-C50.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of breast, NOS

+∞

6.2

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

+∞

6.2

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

+∞

6.2

8507/3-C50.9

ICD-O-3

Invasive micropapillary carcinoma of breast of breast, NOS

+∞

6.2

C76.1

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Thorax

+∞

6.2

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

6.2

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

6.2

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

6.2

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

+∞

6.2

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

6.2

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

6.2

C49.29

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor

+∞

6.2

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

6.2

8480/3-C50.5

ICD-O-3

Mucinous adenocarcinoma of lower-outer quadrant of breast

+∞

6.2

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

17.7

6.2

WX002

NOMESCO Finland

Sedation and analgesia

1.2

6.2

1335

11455

A02BC05

ATC

esomeprazole; systemic

1.1

6.2

3247

29576

N39.3

ICD-10 Finland

Stress incontinence

0.8

6.2

514

6286

SPAT1262

SPAT

Handing over of treatment supplies

0.8

6.2

777

9093

21799

ICD-8 Finland

Benign neoplasm of breast

1.8

6.2

479

C08CA01

ATC

amlodipine; oral

0.9

6.2

2514

26886

SFA30

NOMESCO Finland

Three-surface restoration

0.9

6.2

2591

27656

G47.3

ICD-10 Finland

Sleep apnoea

0.8

6.2

931

10710

JAH01

NOMESCO Finland

Laparoscopy

1.4

6.2

247

1734

J05AB01

ATC

aciclovir; systemic

1.2

6.1

1629

14197

S82

ICPC

Naevus/mole

1.2

6.1

851

7029

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.6

6.1

128

1960

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

1.8

6.1

481

M05BA04

ATC

alendronic acid; oral

1.2

6.1

860

7113

SPAT1193

SPAT

Pap smear

0.8

6.1

394

4969

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.9

6.1

1511

16701

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.4

6.0

240

1682

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4770

29249

2.33

315.56

2.5

2.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

200

34.02

310.35

1.2

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1137

146

87.75

307.65

3.3

1.1

32.31

14.44

u/ml

5.29

1102

129

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1592

3845

4.75

307.65

3.4

1.5

14.75

2.65

ug/l

4.16

1202

2848

(3044640) Blood type and Crossmatch panel - Blood

3621

19199

2.46

307.65

2.3

2.0

—

(3002256) Pathology report gross observation

2184

5568

4.80

307.65

1.3

1.1

—

(40768795) Lymph node Pathology biopsy report

386

102

38.81

307.65

1.1

—

(40768804) Tissue Pathology biopsy report

4539

25863

2.51

307.65

2.4

1.7

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

641

83.75

307.65

3.1

1.0

31.47

16.85

u/ml

2.60

631

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5433

33711

2.55

307.65

7.8

3.5

9.98

10.42

umol/l

2.06

5207

31200

(4035726) Immunohistochemistry procedure

2382

1904

16.53

307.65

1.4

1.2

—

(40768793) Breast Pathology biopsy report

1722

609

34.35

307.65

1.4

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4141

24429

2.27

293.56

4.7

2.1

2.38

2.37

mmol/l

16.27

3719

20358

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7231

54714

2.76

277.34

9.5

5.3

80.22

75.69

u/l

10.74

6916

50293

(3013650) Neutrophils [#/volume] in Blood by Automated count

5592

37853

2.26

275.59

10.7

6.5

3.68

4.09

e9/l

40.15

4971

32284

(40758558) Short blood count panel - Blood

2974

16056

2.24

252.59

7.7

4.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

547

1154

4.90

236.22

1.2

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2594

14525

2.07

190.11

2.2

2.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1152

4953

2.48

157.61

1.7

2.0

0.23

0.21

g/l

8.83

1105

4496

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

910

3975

2.39

118.49

3.4

1.5

95.34

24.73

u/ml

1.45

890

3771

(3023368) Bacteria identified in Blood by Culture

2402

15467

1.72

101.66

4.2

3.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4347

33091

1.58

91.10

5.2

4.6

1.22

mmol/l

0.92

3939

29269

(3003694) ABO and Rh group [Type] in Blood

2317

15306

1.66

86.56

1.4

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3944

29726

1.55

83.72

4.0

3.5

35.42

35.92

g/l

6.65

3633

26914

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4693

36883

1.54

81.43

6.0

5.1

1.23

mmol/l

0.27

3870

31066

(3033658) Prothrombin time (PT) actual/Normal

2323

15932

1.59

72.07

3.4

3.2

94.59

93.85

0.73

2277

15405

(3042936) Bacteria identified in Isolate by Culture

1329

8101

1.72

64.83

1.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1471

9608

1.60

53.90

3.0

2.2

0.83

0.82

mmol/l

0.28

1365

8685

(3018418) pH of Serum or Plasma

2903

22029

1.44

51.54

3.8

3.1

7.40

1.36

588

3651

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

8.16

46.35

6.0

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1047

6596

1.63

43.74

3.2

—

(4281824) Cell count and differential, peritoneal fluid

154

464

3.30

40.34

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

915

5732

1.63

38.85

4.3

2.7

253.27

240.78

u/l

1.70

851

5260

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

324

1476

2.20

37.34

2.9

1.9

2828.38

17.54

u/ml

0.83

283

1176

(40768806) Pleura Pathology biopsy report

107

299

3.54

31.60

1.4

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3757

31370

1.31

31.47

13.3

14.5

1.28

1.23

inr

0.17

1102

8791

(3013826) Glucose [Moles/volume] in Serum or Plasma

4673

40389

1.29

29.24

4.2

3.9

6.47

6.65

mmol/l

9.43

4414

37389

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1415

10321

1.41

28.42

1.9

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

258

1216

2.11

27.32

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7236

74558

0.72

27.29

5.0

5.3

2.86

2.84

mmol/l

1.06

6438

68267

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1857

14263

1.35

27.03

3.1

2.3

2.48

2.46

mmol/l

8.24

1638

12172

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6634

69133

0.75

25.54

5.4

5.9

39.20

39.74

mmol/mol

5.18

5918

63371

(3003434) Protein [Mass/volume] in Pleural fluid

129

461

2.77

25.24

1.3

1.4

32.70

28.59

g/l

3.14

116

391

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2615

21263

1.30

25.07

3.6

2.6

34.24

31.52

u/l

0.42

2481

19929

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

148

571

2.57

24.91

1.2

1.3

0.33

0.41

nmol/l

0.70

420

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7378

68418

1.38

24.83

16.1

11.2

79.14

77.06

ml/min/173m2

17.34

6450

54551

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7075

72987

0.74

24.64

4.4

4.7

4.93

4.87

mmol/l

5.49

6317

67034

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6710

69736

0.76

24.50

3.9

4.1

1.23

1.27

mmol/l

3.91

5883

63009

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

185

812

2.26

23.45

1.2

1.1

56.79

57.24

u/l

0.06

165

712

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

240

1168

2.05

23.38

1.6

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7022

72375

0.75

22.59

4.4

4.6

1.64

1.60

mmol/l

9.47

6238

66120

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

288

1515

1.89

22.43

1.7

1.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

3829

32949

1.25

22.16

5.4

5.9

26.86

28.84

21.96

3551

30411

(3012441) Differential panel - Pleural fluid

101

340

2.94

22.11

1.4

—

(3019225) pH of Specimen

1070

7757

1.40

21.81

4.2

3.6

—

(3019069) Monocytes/100 leukocytes in Blood

3745

32186

1.25

21.77

5.5

6.0

8.75

8.35

8.29

3465

29630

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

226

1107

2.03

21.66

1.6

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

183

827

2.20

21.64

1.6

1.4

—

(3006504) Eosinophils/100 leukocytes in Blood

3714

32023

1.24

20.54

5.3

5.7

2.67

2.91

8.82

3432

29414

(3022096) Basophils/100 leukocytes in Blood

3609

31026

1.24

20.49

5.3

5.8

0.68

0.71

2.98

3327

28405

(3028308) Erythrocytes [#/volume] in Pleural fluid

105

379

2.74

20.25

1.4

44378.46

47463.52

e6/l

0.04

216

(3020682) Albumin/Creatinine [Ratio] in Urine

1957

23194

0.78

20.16

3.4

3.6

5.86

6.89

mg/mmol

0.66

1003

13016

(3018010) Neutrophils/100 leukocytes in Blood

3762

32568

1.24

19.77

5.2

5.7

57.69

56.69

4.97

3480

30014

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

186

887

2.08

19.21

1.3

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.13

19.21

1.1

1.3

638.33

30.62

ug/l

0.56

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

304

2.89

19.04

1.4

1.1

7.33

2.47

ug/l

0.40

232

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

253

1348

1.87

18.99

1.9

2.4

3.64

3.57

g/l

0.32

245

1266

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

827

5873

1.42

18.85

3.5

2.8

1.24

mmol/l

0.55

733

4881

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

250

1333

1.87

18.73

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

250

1333

1.87

18.73

1.3

—

(3012516) Albumin [Mass/volume] in Urine

1861

22021

0.78

18.57

2.9

3.1

441.98

404.16

mg/l

0.11

960

12300

(3023199) Leukocytes [#/volume] in Pleural fluid

111

431

2.55

18.55

1.4

3021.99

2914.88

e6/l

0.03

314

(3021589) Normoblasts [#/volume] in Blood

3550

30681

1.23

18.54

10.2

8.3

0.00

e9/l

0.95

2824

25029

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

167

780

2.12

18.24

1.6

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

167

780

2.12

18.24

1.6

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

279

1554

1.79

18.14

1.6

2.0

94.59

95.18

0.16

273

1454

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

102

392

2.57

17.44

1.1

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

311

1814

1.71

17.22

1.5

1.4

205.21

70.62

pmol/l

3.82

303

1772

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

263

1465

1.79

17.12

1.9

2.3

199.65

182.20

2.31

253

1364

(3009508) Creatinine [Moles/volume] in Urine

1945

22724

0.79

17.09

2.9

3.0

6.14

6.24

mmol/l

0.59

1551

18955

(36304419) Bacteria [Presence] in Urine

2199

18173

1.25

17.06

2.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

961

7115

1.37

17.02

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

565

3809

1.49

16.91

1.7

1.6

—

(3013512) EKG study

2610

22031

1.23

16.57

3.8

3.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

955

7105

1.36

16.37

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

694

4896

1.42

16.36

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

698

4951

1.42

15.95

5.8

5.5

1.27

1.35

mmol/l

1.38

678

4808

(3044889) 12 lead EKG panel

5629

51341

1.21

15.90

3.8

3.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3678

32223

1.21

15.88

5.7

5.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

112

474

2.34

15.61

1.3

1.2

19.89

19.78

u/l

0.01

401

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

436

2836

1.54

15.48

7.5

7.4

24.67

24.70

mmol/l

0.07

419

2709

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

113

485

2.30

15.25

1.3

1.2

64.23

76.96

u/l

1.20

102

425

(3007853) Bacteria identified in Skin by Aerobe culture

1004

7615

1.33

15.08

1.7

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

118

521

2.24

14.91

1.3

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

2222

18624

1.23

14.74

2.9

3.0

0.41

0.42

e6/l

0.06

1633

13911

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

167

849

1.95

14.55

1.3

36.69

37.29

u/l

0.07

154

641

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1303

10295

1.28

14.44

2.6

4.23

5.01

e6/l

1.06

655

5313

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

163

824

1.96

14.44

3.0

1.9

301.60

22.11

u/ml

0.92

145

740

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7581

71687

1.29

13.88

16.3

12.3

22.27

20.24

mg/l

6.22

6153

55249

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

268

1595

1.67

13.83

2.4

3.2

0.36

0.39

u/ml

0.48

153

970

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1199

9423

1.29

13.81

1.9

1.8

29.35

29.48

0.28

1160

9088

(3045788) Cell count panel - Pleural fluid

336

2.50

13.81

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

149

745

1.98

13.64

3.0

2.8

1.63

1.00

1.46

136

645

(3051651) Icteric interference index of Serum or Plasma

292

2.60

13.63

2.5

3.8

—

(3003396) Base excess in Arterial blood by calculation

870

6573

1.33

13.37

5.9

1.10

1.51

mmol/l

2.46

731

5233

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

156

802

1.93

13.19

3.7

4.6

769.14

867.53

iu/ml

0.06

100

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

110

499

2.18

13.07

1.1

—

(3045142) Bone marrow Pathology biopsy report

414

2.29

12.89

1.3

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

160

3.14

12.77

2.5

2.8

—

(3019150) Specific gravity of Urine by Refractometry

1435

16881

0.80

12.69

4.7

1.01

kg/l

0.19

216

2628

(3002582) Erythrocytes [#/volume] in Urine

2348

20047

1.20

12.54

3.0

120.28

68.90

e6/l

0.60

1718

14913

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

278

1716

1.61

12.45

2.3

2.9

—

(3027801) Oxygen [Partial pressure] in Arterial blood

864

6589

1.32

12.41

6.0

5.9

13.55

11.86

kpa

10.92

829

6226

(3014007) Fractional oxyhemoglobin in Arterial blood

487

3390

1.43

12.36

7.6

7.5

94.54

93.41

4.55

487

3380

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

864

6593

1.32

12.35

6.0

5.9

5.13

5.07

kpa

1.01

829

6234

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

315

2.44

12.16

1.3

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.72

12.03

1.6

1.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

482

3387

1.42

11.62

7.7

7.4

0.75

0.70

1.92

482

3368

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

269

2.53

11.60

2.1

1.3

—

(3000991) Gas panel - Venous blood

625

4594

1.36

11.50

7.1

6.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

125

3.31

11.48

1.8

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

272

2.50

11.35

2.1

1.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

483

3411

1.41

11.32

7.7

7.3

1.30

1.41

2.36

483

3388

(40765096) Chromosome analysis panel by Banding

4.65

11.31

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

200

2.76

11.21

2.3

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

200

2.76

11.21

2.3

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

207

2.71

11.06

2.3

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7171

72685

0.82

10.77

4.7

4.8

5.83

5.89

mmol/l

4.73

6364

65884

(3019198) Lymphocytes [#/volume] in Blood

3950

35565

1.16

10.75

5.2

5.6

1.71

1.90

e9/l

11.37

3400

31205

(3013115) Eosinophils [#/volume] in Blood

3993

35985

1.16

10.73

5.3

5.7

0.17

0.19

e9/l

24.99

3386

31278

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3844

34546

1.16

10.70

2.2

2.3

81.67

2781.87

nmol/l

0.50

3351

30355

(3036489) Thrombin time

326

2162

1.50

10.65

1.6

1.8

21.37

21.44

0.07

297

1847

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

313

2062

1.51

10.56

1.9

1.8

1.18

2.32

ug/l

2.79

285

1750

(3019550) Sodium [Moles/volume] in Serum or Plasma

7914

75633

1.30

10.56

17.7

14.4

139.63

139.82

mmol/l

8.35

7700

73392

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

117

591

1.96

10.51

2.2

488.33

1347.00

u/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

10.34

1.0

0.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

361

2460

1.46

10.30

1.9

1.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

119

609

1.93

10.30

1.5

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

139

749

1.83

10.27

1.4

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

243

1525

1.58

10.23

1.1

1.2

—

(3001604) Monocytes [#/volume] in Blood

3845

34642

1.16

10.16

5.1

5.5

0.55

0.56

e9/l

1.13

3219

29714

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

386

2672

1.44

10.14

2.2

1.8

—

(3006315) Basophils [#/volume] in Blood

3853

34737

1.16

10.05

5.1

5.5

0.04

e9/l

9.59

3219

29739

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

484

2.02

9.79

1.8

1.5

5.21

6.84

u/l

0.70

388

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

325

2.24

9.63

5.6

1.1

73.29

299.83

u/ml

1.97

(3018095) Leukocytes [#/volume] in Urine

2783

24541

1.17

9.61

3.5

118.49

126.50

e6/l

0.19

1871

16424

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

482

2.01

9.54

1.9

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1243

14454

0.82

9.49

1.3

11.01

14.23

u/ml

0.94

434

5441

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

781

6094

1.28

9.40

2.1

2.2

37.21

36.48

u/l

0.07

660

5100

(3023103) Potassium [Moles/volume] in Serum or Plasma

7919

75820

1.28

9.40

17.9

14.5

3.93

3.95

mmol/l

5.99

7693

73407

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

374

2.14

9.34

1.1

77.51

73.11

u/l

0.30

323

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

375

2.13

9.28

1.1

18.02

17.49

u/l

0.05

324

(1175426) CD3 cells/100 lymphocytes in Blood

259

2.36

9.08

1.6

1.9

71.72

73.50

0.37

245

(3052851) Hemolysis interference index of Serum or Plasma

301

2040

1.46

8.89

2.8

3.0

—

(3026782) Osmolality of Urine

1577

13341

1.20

8.87

2.7

2.9

492.58

497.42

mosm/kgh2o

0.41

1314

11211

(3014576) Chloride [Moles/volume] in Serum or Plasma

909

7279

1.25

8.80

6.3

5.5

103.99

103.88

mmol/l

0.25

909

7274

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

120

653

1.81

8.66

1.3

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1383

11594

1.20

8.57

2.5

1.20

1.39

e6/l

1.11

737

6566

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

102

531

1.90

8.47

1.9

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

681

5298

1.28

8.39

6.7

6.6

117.80

119.87

g/l

2.26

671

5125

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

904

7277

1.24

8.35

2.2

2.1

7.02

6.04

umol/l

0.95

758

6070

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

453

1.96

8.27

2.0

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

453

1.96

8.27

2.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

453

1.96

8.27

2.0

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7027

71055

0.85

8.22

5.5

1.91

2.05

mu/l

1.85

6299

64987

(3002385) Erythrocyte distribution width [Ratio]

6545

61730

1.16

8.18

19.9

14.3

15.19

15.22

0.12

6451

60450

(3016502) Oxygen saturation in Arterial blood

734

5783

1.27

8.17

6.3

6.2

96.05

95.41

2.09

717

5532

(3021879) Hepatitis B virus core Ab [Presence] in Serum

456

3371

1.35

8.14

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

242

2.32

8.09

1.5

2.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

512

1.89

8.08

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

512

1.89

8.08

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

123

692

1.75

7.98

1.7

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.40

7.82

1.1

—

(3011412) CD3 cells [#/volume] in Blood

358

2.04

7.63

2.5

2.1

1.06

1.46

e9/l

0.81

321

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1332

15045

0.84

7.19

1.3

35.46

37.57

iu/ml

0.20

414

4993

(3035880) pH of Pleural fluid

189

2.40

7.07

1.2

1.1

—

(3014891) Appearance of Pleural fluid

3.48

6.90

1.2

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

540

1.79

6.88

1.2

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

954

7896

1.21

6.71

4.4

4.2

1.03

1.04

mmol/l

0.49

866

7134

(3027945) Reticulocytes/100 erythrocytes in Blood

827

6761

1.22

6.59

2.2

1.78

1.83

0.64

726

5796

(3031040) Bacteria [#/volume] in Urine by Automated count

5329

49863

1.13

6.51

5.0

4.9

5478.29

2531.50

e6/l

1.06

617

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

686

5516

1.24

6.41

3.3

2.3

64.71

63.60

ml/min/173m2

0.36

277

2165

(3008757) Leukocyte morphology finding [Identifier] in Blood

539

1.76

6.36

3.2

3.0

—

(40761536) Microorganisms panel - Urine sediment

708

5738

1.23

6.15

4.4

4.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.84

6.07

3.1

1.2

72.09

71.64

ng/l

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1026

8627

1.19

6.07

2.1

2.4

20.74

21.47

1.00

886

7154

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7982

76916

1.22

6.05

13.2

9.3

24.18

23.33

u/l

2.22

7707

73384

(40768443) Skin Pathology biopsy report

409

3116

1.30

5.99

1.3

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6107

62013

0.89

5.92

4.6

14.97

14.89

pmol/l

1.50

5447

56239

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1827

16092

1.14

5.91

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1507

0.59

5.85

2.3

2.2

148.06

63.76

ug/min

0.92

801

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

402

1.84

5.83

1.3

1.4

—

(3022475) Manganese [Moles/volume] in Blood

4.91

5.75

1.1

—

(21494755) Public health laboratory ask at order entry panel

365

4608

0.77

5.69

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

485

1.75

5.66

2.4

2.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1567

17188

0.87

5.60

1.7

53884361.25

36448249.40

pmol/l

0.43

1223

13935

(3023487) Leukocytes [#/volume] in Peritoneal fluid

131

2.48

5.53

1.8

2.3

1136.35

1327.68

e6/l

0.09

(3044007) Cell count panel - Peritoneal fluid

104

2.65

5.37

2.0

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

117

727

1.59

5.35

2.6

3.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1584

17304

0.88

5.30

1.3

1.84

1.45

u/ml

0.35

354

4568

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.81

5.15

1.3

1.7

37.99

21.87

g/l

5.51

(3020779) Urea [Moles/volume] in Serum or Plasma

560

4515

1.23

5.15

5.9

6.0

9.31

9.87

mmol/l

1.18

535

4255

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

139

909

1.51

5.08

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

113

2.52

5.08

1.4

1.2

58.50

57.74

0.04

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

137

2.37

5.06

1.8

2.5

45.70

48.13

0.43

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.57

5.04

1.4

1.2

20.67

12.36

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.07

5.01

1.9

2.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

511

1.68

5.00

3.3

2.5

58.32

59.21

0.14

416

(3018834) Bilirubin.total [Presence] in Urine by Test strip

8.18

4.99

3.3

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

667

5494

1.21

4.96

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

104

642

1.60

4.92

1.2

20.86

18.66

u/l

0.59

507

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

263

1940

1.34

4.91

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2697

28422

0.90

4.81

4.4

4.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

371

2879

1.28

4.78

7.8

7.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

108

680

1.57

4.72

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.61

4.71

1.4

1.2

3.44

2.40

0.22

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

452

3600

1.24

4.68

1.4

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1252

0.61

4.66

1.3

1.7

0.84

0.78

nmol/l

0.23

1018

(3042631) Mycobacterium sp identified in Specimen

111

709

1.54

4.57

3.0

—

(4034850) Laboratory test

205

2715

0.73

4.55

12.2

9.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

718

1.54

4.54

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

300

1.84

4.45

1.2

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1794

16049

1.12

4.41

1.6

1.7

1.23

1.07

mg/l

1.26

1388

12216

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1075

9319

1.15

4.32

2.1

2.3

2.35

2.41

g/l

2.40

976

8454

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

157

2149

0.71

4.31

1.5

9.98

9.27

iu/ml

0.02

463

(3000850) Epithelial cells [#/volume] in Urine

1587

14113

1.13

4.31

2.5

8.48

7.38

e6/l

1.21

1395

12485

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

4.56

4.28

1.7

1.0

1.49

1.55

ug/l

—

(3020630) Protein [Mass/volume] in Serum or Plasma

645

5378

1.19

4.24

2.6

1.5

65.39

66.83

g/l

4.42

578

4698

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.77

4.22

1.9

2.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

136

1899

0.70

4.20

1.5

1.8

—

(3033799) Differential panel - Peritoneal fluid

100

2.46

4.19

2.1

2.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

747

6315

1.18

4.17

3.0

3.1

82.93

82.47

ng/l

0.05

630

5238

(40761535) Cells panel - Urine sediment

552

6425

0.83

4.17

3.7

3.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

174

1238

1.39

4.15

2.9

3.3

58.93

57.48

0.65

174

1238

(3036481) Cortisol [Moles/volume] in Serum or Plasma

770

6531

1.17

4.13

2.3

1.8

389.55

369.94

nmol/l

1.85

708

5880

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

146

1010

1.43

4.09

2.1

2.0

25.95

25.16

mg/l

0.06

258

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.93

4.01

1.8

3.9

0.62

1.87

mg/l

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4701

44253

1.09

4.01

3.1

2.9

48.06

40.47

u/l

5.10

4252

40456

(40768441) Liver Pathology biopsy report

327

1.75

3.94

1.2

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

265

1.82

3.83

1.3

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

430

3489

1.22

3.80

3.4

3.3

2.18

2.14

mmol/l

0.07

337

2677

(3013139) Helicobacter pylori Ag [Presence] in Stool

513

5954

0.84

3.78

1.2

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

400

1.65

3.72

1.7

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

261

1.81

3.70

1.3

1.4

—

(40761511) CBC panel - Blood by Automated count

7724

74606

1.14

3.69

15.2

11.9

—

(3012501) Base excess in Blood by calculation

181

1324

1.35

3.67

3.1

3.5

2.79

2.73

mmol/l

0.11

143

940

(3022948) Iron [Moles/volume] in Serum or Plasma

1166

10273

1.13

3.67

2.1

2.4

12.08

12.75

umol/l

2.67

1073

9355

(3023323) Follitropin [Units/volume] in Serum or Plasma

347

2766

1.24

3.64

1.4

1.3

46.75

37.01

iu/l

5.07

292

2433

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

117

796

1.45

3.63

1.3

—

(40758292) HTLV I+II Ab panel - Serum

4.06

3.62

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

238

2977

0.78

3.57

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.95

3.56

1.3

1.2

—

(3008295) Osmolality of Serum or Plasma

104

696

1.47

3.53

1.4

1.5

275.63

273.56

mosm/kgh2o

0.42

517

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

294

2313

1.26

3.48

3.8

3.5

25.29

25.27

mmol/l

0.05

270

2082

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

749

6431

1.16

3.46

1.4

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

337

2695

1.24

3.45

3.8

3.5

24.56

24.51

mmol/l

0.10

321

2628

(3003338) MCHC [Mass/volume]

5924

59709

0.92

3.45

22.1

16.4

329.82

330.36

g/l

5.45

5879

59252

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

5.20

3.45

1.0

352.00

112.75

u/l

—

(3022313) Gas panel - Capillary blood

327

2610

1.24

3.41

3.6

3.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.80

3.41

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

640

5442

1.17

3.37

3.7

3.8

1.43

0.74

6.20

283

1246

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

881

0.61

3.37

1.1

21.06

14180.38

iu/ml

0.55

168

(3009343) pH of Capillary blood

439

3621

1.20

3.31

3.4

3.3

7.43

7.42

1.59

458

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

376

1.62

3.28

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

119

2.15

3.28

2.1

1.9

5291.80

31176.92

e6/l

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

622

1.47

3.20

5.1

6.3

11.77

12.40

mg/l

0.77

555

(3008898) HLA-B27 [Presence]

181

2307

0.76

3.19

1.0

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

291

3503

0.81

3.17

1.3

2.63

0.73

u/ml

0.67

323

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

380

1.61

3.16

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

312

1.67

3.16

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

312

1.67

3.16

1.4

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

136

978

1.37

3.14

1.8

1.73

1.66

mmol/l

0.32

131

960

(40761539) Cells [Type] in Urine sediment by Light microscopy

135

2.04

3.11

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

169

1.92

3.11

1.0

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2379

21932

1.09

3.08

2.8

2.9

1337.91

1267.16

ng/l

0.38

2015

18523

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

441

3667

1.19

3.07

3.4

3.3

5.23

5.24

kpa

0.11

417

3420

(3000494) Fungus identified in Specimen by Culture

936

8229

1.13

3.07

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.90

3.02

1.0

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

1907

20055

0.91

3.00

4.6

0.00

estimate

1.47

660

6358

(3037522) Nuclear Ab [Titer] in Serum

1001

10872

0.89

2.97

1.3

1.4

475.77

616.91

titre

2.19

246

2600

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1089

0.67

2.97

1.1

0.94

1.32

u/ml

0.39

524

(3006922) Hepatitis E virus Ab [Presence] in Serum

418

1.55

2.96

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

587

5013

1.16

2.96

2.3

2.2

68.79

71.30

e9/l

0.89

436

3772

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

2.95

0.0

1.1

—

(4200892) Spirometry reversibility

509

5778

0.86

2.93

1.4

1.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

3.48

2.92

1.4

1.1

16.15

14.54

g/l

0.28

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

126

907

1.37

2.92

1.1

—

(3022689) Creatine [Moles/volume] in Urine

234

0.38

2.91

1.4

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

849

9297

0.88

2.90

1.8

2.0

137.00

118.15

ug/g

0.29

640

7105

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

245

2968

0.80

2.86

1.4

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

113

2.09

2.86

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

314

1.63

2.85

2.2

2.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2449

22707

1.08

2.71

2.5

2.2

60.06

59.07

u/l

0.28

2201

20511

(3005322) IgE [Units/volume] in Serum or Plasma

404

4637

0.85

2.69

1.3

130.36

178.38

u/ml

1.73

364

4260

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

137

1.94

2.65

1.1

—

(3010421) pH of Blood

201

1570

1.26

2.63

3.0

3.3

7.42

0.35

192

1434

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

404

3393

1.18

2.56

1.3

—

(3000012) Reticulocyte production index

105

753

1.37

2.54

1.9

1.8

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

695

1.39

2.53

1.9

1.6

32.48

31.98

0.51

688

(40767503) Oxygen content in Capillary blood by calculation

164

1257

1.29

2.51

2.4

2.5

16.22

16.17

0.05

613

(3022145) Colonoscopy Study observation

875

7760

1.12

2.51

1.3

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.35

2.50

3.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

598

5182

1.14

2.50

3.0

2.9

4.35

4.41

pmol/l

0.80

529

4498

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

184

2259

0.79

2.47

1.3

3.15

4.79

u/ml

0.34

259

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

161

1238

1.28

2.42

1.4

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1041

0.70

2.40

1.3

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

356

0.50

2.40

1.3

1.5

—

(3026008) Bacteria identified in Urine by Culture

2932

27479

1.07

2.37

3.3

3.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

119

881

1.33

2.37

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.16

2.36

3.2

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

188

2288

0.80

2.36

1.3

10.14

5.65

u/ml

0.41

414

(3025468) Yersinia sp identified in Specimen by Organism specific culture

123

918

1.32

2.32

1.6

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.57

2.31

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

440

1.45

2.21

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

124

934

1.31

2.21

1.6

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

578

5045

1.13

2.19

3.6

1.03

0.52

4.76

238

1113

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

210

2502

0.82

2.17

1.3

37.98

48.66

u/ml

0.19

159

(3049717) Cytology report of Urine Cyto stain

201

1612

1.23

2.14

2.3

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1102

9976

1.10

2.14

4.7

4.8

34.19

33.59

1.01

678

6571

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

711

7718

0.90

2.14

1.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

262

0.45

2.14

5.9

10.4

834.33

828.42

nmol/l

0.01

250

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

444

1.44

2.12

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.62

2.11

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

153

1878

0.80

2.11

1.3

1.11

5.75

u/ml

2.13

142

(1761868) Lipid panel - Serum or Plasma

2281

23527

0.93

2.11

2.9

3.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

106

787

1.33

2.11

1.3

97.82

122.36

u/ml

1.78

181

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

220

2598

0.83

2.09

1.5

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

2.08

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

121

917

1.30

2.08

1.6

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

862

0.70

2.06

1.2

1.3

7.50

7.51

mmol/l

0.01

740

(21494434) Karyotype in Bone marrow

415

1.45

2.05

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

117

885

1.30

2.05

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

116

877

1.30

2.04

1.3

—

18.79

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

123

938

1.29

2.03

1.6

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

600

5279

1.12

2.02

3.8

3.9

0.24

0.06

3.97

245

1087

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

167

1323

1.24

2.01

1.5

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

121

922

1.29

2.01

1.6

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

346

1.48

1.96

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.28

1.96

1.5

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

932

0.72

1.94

1.1

1.33

0.81

u/ml

0.29

349

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

193

2283

0.83

1.90

1.5

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

338

3813

0.86

1.89

1.8

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

961

0.73

1.89

1.1

6.66

2.34

u/ml

0.68

435

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

262

0.49

1.89

1.1

1643.62

1593.41

miu/ml

0.05

262

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.91

1.89

1.1

—

(3003181) Sodium [Moles/volume] in Urine

184

1485

1.22

1.89

1.3

1.4

67.14

62.10

mmol/l

0.72

141

1188

(3035350) Ketones [Presence] in Urine by Test strip

3662

37119

0.94

1.88

4.0

4.2

0.00

estimate

0.01

720

6950

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.04

1.87

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

161

1283

1.24

1.87

2.2

2.7

1.47

1.59

mg/l

1.36

139

1143

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

197

2317

0.83

1.84

1.3

1.7

0.24

0.23

g/l

0.30

186

2183

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

609

1.34

1.83

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

818

0.72

1.81

1.1

0.34

0.94

u/ml

1.89

378

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

177

0.44

1.80

2.1

2.8

6.10

6.76

mg/l

—

137

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

586

0.67

1.79

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

164

0.42

1.78

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

124

966

1.26

1.77

1.6

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

560

0.66

1.76

1.1

1.2

—

145.00

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

732

0.71

1.74

1.0

5.66

2.80

u/ml

0.61

320

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

202

2356

0.84

1.74

1.3

1.6

1.17

1.20

g/l

0.67

192

2218

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

205

2386

0.84

1.72

1.6

1.7

145.45

295.28

titre

1.99

143

(3037467) Urinalysis macro (dipstick) panel - Urine

5345

51347

1.06

1.70

4.6

4.7

—

(3021901) Oxygen saturation in Capillary blood

128

1007

1.25

1.69

2.6

2.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

351

0.59

1.68

1.4

1.5

1.00

1.27

nmol/l

0.70

279

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.86

1.68

1.0

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

211

0.46

1.68

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.45

1.64

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.75

1.61

1.0

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2309

23623

0.94

1.60

2.0

2.1

148.69

168.71

u/l

1.01

2145

21847

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

741

0.73

1.59

2.1

1.5

38.43

33.28

0.43

422

(3022621) pH of Urine by Test strip

495

5378

0.90

1.58

3.7

3.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

522

0.68

1.57

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.20

1.56

1.1

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

498

1.34

1.56

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

532

1.33

1.56

1.9

2.4

—

(3016018) Differential panel - Cerebral spinal fluid

695

1.29

1.56

1.6

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

539

4795

1.11

1.55

1.3

—

(3004775) Volume in Urine collected for unspecified duration

497

0.67

1.55

2.1

2.3

633.05

611.39

0.10

354

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.94

1.55

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

229

0.51

1.53

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

519

0.68

1.53

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

240

0.53

1.50

1.9

1.6

9.85

8.83

ug/l

0.41

240

(3007916) DNA double strand Ab [Titer] in Serum

124

0.40

1.49

1.2

1.3

—

214.19

—

(3028026) IgM [Mass/volume] in Serum or Plasma

422

3714

1.12

1.49

1.8

1.5

1.25

1.28

g/l

0.13

378

3355

(3026389) Candida sp identified in Specimen by Organism specific culture

113

1370

0.81

1.49

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

1098

0.78

1.49

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

289

0.58

1.48

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

271

3042

0.87

1.48

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.55

1.48

1.0

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

685

0.73

1.46

1.0

1.1

4.38

2.67

u/ml

0.30

254

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

164

0.48

1.46

1.4

1.7

—

81.35

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.89

1.46

1.2

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.94

1.46

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

443

0.66

1.46

1.4

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

739

0.74

1.44

1.3

1.2

—

75.04

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.45

1.41

2.6

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.91

1.41

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.91

1.41

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

155

1809

0.84

1.40

1.4

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

750

1.26

1.40

1.0

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

185

1.54

1.40

2.6

2.0

157.03

166.43

0.23

169

(3024869) Neuronal Ab [Presence] in Serum

101

1.75

1.40

1.1

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

944

0.78

1.38

3.8

4.9

367.21

369.97

umol/l

0.06

806

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

597

0.72

1.37

1.0

1.03

0.31

u/ml

—

161

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

408

1.35

1.36

2.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

409

1.35

2.1

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.13

1.34

1.7

1.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.79

1.33

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.56

1.33

3.7

3.3

—

(3002032) Base excess in Venous blood by calculation

634

5736

1.09

1.33

3.3

2.13

2.21

mmol/l

0.25

548

4985

(3005719) IgG [Mass/volume] in Serum or Plasma

530

4756

1.10

1.33

2.8

2.5

9.83

10.49

g/l

2.85

477

4324

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

715

0.75

1.30

1.3

1.2

8.00

46.00

u/ml

—

(3000492) Spirometry study

698

6349

1.09

1.30

1.4

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

155

1285

1.19

1.30

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

304

3349

0.89

1.28

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

751

1.24

1.28

1.0

1.1

—

(3019060) Gas panel - Arterial blood

450

4018

1.10

1.26

3.7

4.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1797

18389

0.95

1.24

3.9

4.1

—

(3037756) Immunofixation for Serum or Plasma

150

1246

1.18

1.24

1.4

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

368

3998

0.90

1.23

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

182

2065

0.86

1.21

1.7

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

123

1007

1.20

2.5

2.6

33.98

32.03

umol/l

0.47

103

897

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

526

0.73

1.20

1.1

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

142

1178

1.19

1.20

2.5

2.7

8.15

8.09

kpa

0.18

135

1155

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

110

891

1.21

1.20

1.1

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1723

17632

0.95

1.20

2.5

2.1

6153.41

4988.84

umol/l

0.49

1453

14969

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

558

0.74

1.18

1.0

47.66

50.66

ng/l

0.16

375

(3013005) Retinol [Moles/volume] in Serum or Plasma

226

1.43

1.18

1.1

1.6

2.03

2.00

umol/l

0.08

209

(3001019) Free T4 and TSH panel - Serum or Plasma

314

3427

0.90

1.16

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

419

0.70

1.14

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

261

1.39

1.13

3.2

2.1

0.24

0.21

e9/l

0.31

229

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

278

1.38

1.13

3.1

2.1

535.35

562.60

e6/l

0.07

235

(1001926) Buprenorphine [Presence] in Urine by Screen method

840

0.79

1.13

2.9

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

163

1851

0.86

1.12

1.2

1.3

34.96

49.45

u/ml

0.52

203

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

619

0.76

1.11

1.2

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

583

6161

0.92

1.10

2.2

2.4

5.26

5.74

ug/l

0.35

468

5177

(3021447) Carbon dioxide [Partial pressure] in Venous blood

629

5743

1.08

1.10

3.3

5.80

5.87

kpa

0.85

606

5567

(3034891) Synovial lining cells/100 cells in Synovial fluid

404

0.70

1.10

1.7

1.5

3.70

4.82

—

(3035933) Granulocytes/100 leukocytes in Blood

125

1.57

1.09

1.2

1.9

—

(3025130) Human papilloma virus identified in Specimen

138

1154

1.18

1.09

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

174

1482

1.16

1.09

2.1

128.68

127.70

g/l

0.18

110

1063

(3009261) Glucose [Presence] in Urine by Test strip

3741

37539

0.96

1.08

4.1

4.2

0.00

estimate

2.04

679

6353

(3025159) Blasts/100 leukocytes in Blood

558

5076

1.08

3.7

3.9

0.63

0.06

0.62

198

923

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

548

0.75

1.07

1.0

1165.61

361.44

ng/l

0.47

374

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2083

21155

0.96

1.06

1.6

1.29

1.33

mmol/l

2.18

1718

17620

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.34

1.06

1.0

—

(3047189) Immunofixation for 24 hour Urine

166

1.48

1.06

1.4

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

201

0.59

1.05

1.3

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

3706

37181

0.96

1.05

5.4

5.5

0.00

estimate

1.60

667

6305

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

673

1.23

1.05

2.0

2.3

2.53

2.97

u/field

0.21

232

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.75

1.04

1.0

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.67

1.04

1.1

1.3

1560008.25

434334.61

nmol/l

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1099

0.83

1.04

1.3

1.5

0.56

0.69

g/l

1.06

826

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

167

1.47

1.03

1.9

2.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

250

1.38

1.02

1.3

72.46

73.88

nmol/24h

0.05

250

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

554

0.76

1.01

1.0

755.44

701.98

ng/l

0.29

360

(3040151) Glucose [Moles/volume] in Capillary blood

686

1.22

1.00

6.4

10.0

7.08

7.51

mmol/l

0.48

560

(44813793) Dust mix specific IgE antibody measurement

574

0.77

0.99

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

345

1.31

0.99

8.2

10.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

129

0.53

0.98

1.1

1.3

22.02

27.23

nmol/l

—

103

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.64

0.97

1.4

2.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

102

842

1.19

0.96

1.1

1.2

292.72

285.22

u/ml

0.10

531

(3039162) Centromere protein B Ab [Units/volume] in Serum

1132

0.84

0.96

1.2

1.3

89.23

60.89

u/ml

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

636

0.79

0.95

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

570

0.77

0.95

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

682

1.21

0.95

1.2

328.78

357.16

nmol/l

0.61

564

(3003327) Ova and parasites identified in Stool by Light microscopy

234

2558

0.89

0.94

1.6

1.7

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

656

0.79

0.93

1.0

1.1

—

72.11

—

(3016879) Cocaine [Presence] in Urine

979

0.83

0.93

2.6

1.5

—

(3000285) Sodium [Moles/volume] in Blood

117

0.50

0.93

1.5

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

140

0.56

0.93

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

107

1.56

0.93

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

321

0.70

0.92

1.0

1.1

1.25

1.06

u/l

0.47

151

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

402

1.27

0.91

1.9

2.0

0.95

2.28

u/field

2.02

255

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.10

0.90

1.2

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

674

0.80

0.90

1.3

1.2

2.20

9.98

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

695

0.80

0.89

1.3

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

386

1.27

0.89

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

563

5899

0.93

0.89

1.6

1.41

1.39

0.16

473

5106

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1195

11227

1.05

0.89

1.4

—

(3015736) pH of Urine

2968

29818

0.96

0.88

3.6

3.9

5.87

5.90

0.17

202

1786

(3019977) pH of Arterial blood

309

1.30

0.88

2.7

2.4

7.42

0.05

106

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1496

14142

1.05

0.86

3.4

3.8

129.96

298.99

ng/l

4.64

1177

10828

(3032868) Hemoglobin electrophoresis panel in Blood

1.83

0.86

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.96

0.85

8.8

1.0

—

(3044927) Protein electrophoresis panel - Urine

776

0.82

0.85

1.1

1.2

—

(3016750) Collection duration of Urine

360

0.74

0.84

2.1

2.2

469.11

503.68

min

1.91

280

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

478

1.23

0.84

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

135

1157

1.15

0.83

1.2

0.15

0.27

nmol/l

1.71

(3020961) Endomysium IgA Ab [Titer] in Serum

333

3550

0.92

0.83

1.1

508.44

202.27

titre

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

579

0.80

0.82

1.3

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

300

2696

1.10

0.82

1.7

1.6

1.60

1.63

g/l

0.18

245

2277

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

578

0.80

0.81

1.3

1.4

—

(1002224) Polysomnography panel

219

2379

0.90

0.81

1.1

—

(3017704) Immunofixation for Urine

335

0.73

0.81

1.5

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

238

2117

1.11

0.81

1.9

2.1

360.03

600.44

ug/l

1.13

211

1960

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

577

0.80

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

577

0.80

1.3

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.64

0.80

1.3

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

598

1.20

0.79

3.8

3.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

378

0.75

0.79

1.1

—

(3011288) Drugs identified in Urine by Screen method

726

0.82

0.79

1.9

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

333

0.74

0.78

1.8

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

178

1.38

0.78

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

160

0.61

0.78

1.0

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

264

1.30

0.77

2.3

2.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

2.03

—

(3037121) Protein [Mass/volume] in Urine

245

2191

1.10

0.76

3.0

2.4

0.16

0.33

g/l

6.18

557

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1866

17775

1.04

0.76

2.2

2.3

3.08

3.00

mg/l

0.57

1521

15076

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

123

1057

1.14

0.75

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

923

0.85

0.75

1.2

30.99

24.77

u/l

0.44

797

(3010838) Calcium [Moles/time] in 24 hour Urine

189

1670

1.11

0.74

1.7

1.9

5.55

5.00

mmol/24h

1.35

162

1439

(42529582) MDA5 Ab [Presence] in Serum by Line blot

193

0.66

0.74

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

193

0.66

0.74

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

193

0.66

0.74

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

193

0.66

0.74

1.2

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.67

0.74

3.1

1.4

—

(3001729) Color of Synovial fluid

1.64

0.74

2.7

1.8

—

(40757373) Influenza virus identified in Isolate

114

1.46

0.73

1.2

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

129

0.61

0.73

1.0

1.4

—

(3015183) Erythrocyte sedimentation rate

268

1.28

0.70

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.72

0.70

1.0

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

761

7121

1.05

0.70

1.6

—

(3025941) Bacteria identified in Stool by Culture

444

4088

1.07

0.70

1.2

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.89

0.69

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

135

1488

0.89

0.68

1.3

3.59

3.74

mmol/l

0.83

128

1393

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.68

0.68

1.1

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

189

0.67

0.68

1.5

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

711

0.84

0.66

1.2

1.5

6.35

6.75

g/l

0.36

503

(3024139) IgG subclass 3 [Mass/volume] in Serum

710

0.84

0.66

1.2

1.5

0.42

0.40

g/l

0.10

504

(3008152) Bicarbonate [Moles/volume] in Arterial blood

416

3834

1.07

0.65

5.9

6.3

25.09

24.88

mmol/l

0.60

402

3637

(3028192) IgG subclass 2 [Mass/volume] in Serum

709

0.84

0.65

1.2

1.5

2.60

2.90

g/l

0.78

501

(3043409) Potassium [Moles/volume] in Arterial blood

209

1874

1.10

0.65

3.9

4.0

3.82

3.81

mmol/l

0.19

209

1864

(3020891) Body temperature

276

2508

1.08

0.64

4.1

4.3

—

(3012565) Volume of 24 hour Urine

299

1.25

0.63

1.9

1.6

1920.72

1854.68

0.16

263

(1616796) Gas panel - Central venous blood

139

1222

1.12

0.63

3.3

3.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

675

0.84

0.63

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

264

0.74

0.63

3.0

2.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

247

1.27

0.62

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

513

0.82

0.61

3.9

1.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.48

0.61

1.1

1.3

20.04

80.20

ng/l

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.60

0.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

350

0.78

0.60

1.1

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.60

0.0

2.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

103

1.43

0.59

1.0

93.69

77.89

ug/l

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

102

884

1.13

0.59

1.1

125.68

123.72

0.19

786

(3012494) Peanut IgE Ab [Units/volume] in Serum

194

0.71

0.59

1.0

0.14

1.07

u/ml

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.54

0.59

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

102

1130

0.88

0.59

1.6

1.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

627

0.84

0.58

1.5

1.4

—

3.80

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

510

0.83

0.58

1.7

—

(3017569) Oxygen content in Arterial blood

276

1.25

0.58

2.5

2.1

—

(3000330) Specific gravity of Urine by Test strip

395

4111

0.94

0.58

3.2

3.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

700

0.85

0.58

1.1

1.2

—

35.65

—

(40762365) Oxygen content in Arterial blood by calculation

1.52

0.57

1.5

2.1

13.85

15.13

ml/dl

1.59

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

146

1.34

0.57

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1897

19063

0.97

0.57

3.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

179

1607

1.09

0.57

1.5

1.3

—

(3048879) Bone marrow aspiration report

138

1.35

0.56

2.5

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

109

1198

0.89

0.56

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

331

1.22

0.56

1.6

1.8

—

(3029075) Extractable nuclear Ab panel - Serum

216

1.27

0.56

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

296

1.23

0.55

1.9

1.6

0.37

0.36

ug/l

0.06

183

(3020874) Milk IgE Ab [Units/volume] in Serum

356

0.80

0.55

1.0

0.38

1.18

u/ml

—

116

(4062490) Immunoglobulin typing, IgG

706

0.86

0.54

1.2

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

435

4501

0.95

0.54

2.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

137

1481

0.91

0.53

1.5

1.4

823.50

1463.26

e6/l

0.68

101

1232

(44816559) Phosphatidylethanol [Mass/volume] in Blood

965

0.88

0.53

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

167

0.70

0.53

1.3

91.50

133.13

nmol/l

—

108

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

137

1479

0.91

0.52

1.5

1.4

26.51

34.33

e6/l

0.20

1171

(3015235) Bicarbonate [Moles/volume] in Capillary blood

158

1418

1.10

0.52

2.6

2.9

25.72

25.41

mmol/l

0.43

150

1390

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

786

0.87

0.52

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

143

0.69

0.51

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1024

0.89

0.51

1.8

1.6

57.99

55.36

0.29

619

(3000764) Benzodiazepines [Presence] in Urine

1065

0.89

0.51

2.4

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.40

0.51

1.3

1.8

83.67

48.56

umol/l

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

655

1.14

0.51

1.1

93.31

93.57

0.03

613

(3000570) Elastase.pancreatic [Mass/mass] in Stool

215

2269

0.93

0.50

1.3

1.4

279.58

294.39

ug/g

0.50

117

1288

(3034274) Bile acid [Moles/volume] in Serum --fasting

510

0.85

0.49

1.5

1.7

6.47

7.62

umol/l

0.33

364

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

256

1.23

0.49

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

153

0.71

0.49

3.7

5.7

—

(3028300) Cannabinoids [Presence] in Urine

1072

0.90

0.49

2.4

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

106

0.65

0.48

2.7

1.8

13.96

18.79

umol/l

—

106

(3007164) IgA [Mass/volume] in Serum or Plasma

1390

13990

0.97

0.48

1.5

1.3

2.26

2.35

g/l

0.99

729

7790

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

248

1.23

0.48

1.1

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

248

1.23

0.48

1.1

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

116

1031

1.11

0.48

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

520

4882

1.05

0.47

2.7

2.8

4.56

4.46

kpa

0.52

499

4730

(4146454) Self-monitoring of blood glucose

854

1.12

0.47

2.4

2.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

169

1.28

0.47

1.1

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

143

1.30

0.47

5.2

2.3

—

(3024928) Oxygen saturation in Venous blood

139

1248

1.09

0.47

2.2

3.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

337

3493

0.94

0.47

1.2

1.4

—

(3027008) Opiates [Presence] in Urine

1066

0.90

0.45

2.4

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.58

0.45

1.0

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3316

32974

0.98

0.45

2.0

99.37

99.75

pmol/l

0.14

1427

14940

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

206

1.24

0.44

1.0

1.1

89.08

92.47

0.18

(3028433) Virus identified in Specimen by Culture

206

1.24

0.44

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

112

999

1.10

0.44

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

110

1.34

0.44

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

998

10079

0.97

0.44

7.1

6.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

492

0.86

0.43

1.3

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.64

0.43

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

690

0.88

0.43

1.7

1.6

18.00

23.29

u/ml

0.78

158

(3024263) Appearance of Synovial fluid

388

1.16

0.43

1.7

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

128

0.69

0.43

1.4

1.6

1.21

1.19

mmol/l

—

123

(21494890) Protein electrophoresis panel - 24 hour Urine

545

1.14

0.42

1.6

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

199

1.23

0.42

1.0

1.1

96.62

94.71

0.07

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.36

0.41

9.3

7.0

—

(3005033) Fetal Nuchal fold Thickness US

490

0.86

0.41

1.2

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

688

0.88

0.41

2.3

2.9

25.21

30.48

mg/l

0.16

460

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

224

0.79

0.41

1.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

2.7

—

1.23

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

4.8

—

361.25

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

272

1.19

0.40

1.4

1.3

0.78

1.21

nmol/l

2.55

224

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.40

0.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

509

0.87

0.40

1.2

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

634

6440

0.96

0.40

2.6

2.9

201.51

187.33

ng/l

0.34

578

5875

(1761482) Bacteria [#/volume] in Urine by Culture

196

2052

0.94

0.40

3.8

4.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

327

1.17

0.40

1.3

1.6

3.97

4.42

nmol/l

0.08

263

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

212

0.79

0.40

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

135

0.73

0.39

1.0

1.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.44

0.39

1.2

1.1

4.76

11.99

mg/l

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

183

1.23

0.39

1.1

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

735

1.11

0.39

1.6

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1883

18149

1.02

0.38

1.5

21.77

21.83

nmol/l

0.06

1528

15079

(3027456) Digoxin [Moles/volume] in Serum or Plasma

190

1748

1.07

0.38

3.2

3.4

0.81

0.82

nmol/l

0.12

148

1390

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.34

0.38

1.0

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

105

945

1.09

0.37

1.2

3.37

3.68

u/ml

0.09

313

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

330

1.16

0.37

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

515

0.88

0.37

1.1

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

158

1.24

0.36

1.1

1.3

179.73

60.27

mu/l

0.60

110

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

114

1.29

0.36

1.4

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

358

1.15

0.36

1.9

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

160

1469

1.07

0.35

1.2

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.62

0.35

1.0

—

4.39

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3086

30636

0.98

0.35

2.6

2.8

123.82

97.00

ug/l

5.70

2754

27996

(3045414) Leukocytes [Presence] in Urine

355

3635

0.96

0.35

2.0

1.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2906

28169

1.02

0.35

3.7

3.6

34.04

58.79

ng/l

1.32

2024

18689

(3025018) Bordetella pertussis Ab [Titer] in Serum

429

0.87

0.34

1.1

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

537

5450

0.96

0.34

1.2

146.87

147.96

iu/ml

0.02

200

2171

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2691

0.95

0.34

1.9

1.4

7.66

7.61

g/l

0.16

225

2338

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

531

0.89

0.33

1.5

1.3

1.59

1.42

nmol/l

0.45

480

(3027944) Amphetamines [Presence] in Urine

1043

0.92

0.33

2.4

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2687

0.95

0.33

1.9

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

385

0.87

0.33

1.3

1.4

0.94

1.12

promille

0.35

283

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

117

1066

1.08

0.32

1.1

8.70

16.27

au/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2686

0.95

0.32

1.9

1.4

3.69

3.66

g/l

0.18

225

2335

(36660697) Celiac disease serology panel - Serum

621

6277

0.97

0.32

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

567

1.11

0.32

2.2

1.9

0.62

0.96

g/24h

1.12

227

(3036670) Protein [Mass/volume] in Synovial fluid

243

1.17

0.32

1.3

39.85

38.61

g/l

0.22

130

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

108

1142

0.93

0.31

1.7

1.5

—

(3023419) Bacteria identified in Sputum by Culture

109

992

1.08

0.31

2.6

2.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

154

1607

0.94

0.31

3.8

3.6

27.22

23.16

mg/l

0.54

1023

(3028679) Herpes simplex virus Ab [Presence] in Serum

280

1.16

0.31

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

503

1.11

0.31

1.2

1.4

2.42

2.19

mmol/l

0.45

466

(3017732) Neutrophils [#/volume] in Blood

527

5012

1.03

0.30

3.0

2.8

3.72

4.70

e9/l

5.38

405

3826

(3030981) Hyaline casts [#/volume] in Urine by Automated count

314

3208

0.96

0.30

2.4

0.33

0.31

e6/l

0.07

309

3078

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

202

2086

0.95

0.30

1.1

6.72

8.77

u/ml

0.31

198

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

277

0.85

0.30

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

109

1.26

0.29

9.0

7.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

163

1693

0.94

0.29

1.3

566.78

515.03

mg/l

0.45

157

1591

(4212803) Bone marrow aspirate examination

1.25

0.29

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

484

0.89

0.29

1.0

1.1

5.55

9.22

iu/ml

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.33

0.29

1.1

1.0

—

(3044941) Cell count panel - Synovial fluid

120

1258

0.94

0.29

1.7

1.4

—

(3011648) Oxygen content in Venous blood

459

1.11

0.29

1.6

2.2

10.07

10.81

0.61

459

(3015076) Soybean IgE Ab [Units/volume] in Serum

276

0.85

0.29

1.0

0.05

0.28

u/ml

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.29

0.28

11.8

11.9

4.01

4.16

mmol/l

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

316

3220

0.96

0.27

2.9

3.0

25.51

25.68

mmol/l

0.41

308

3124

(40768446) Kidney Pathology biopsy report

169

0.81

0.27

1.9

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

211

0.84

0.27

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

266

1.14

0.27

1.6

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

104

954

1.07

0.26

1.2

1.3

516.91

292.54

pmol/l

0.43

831

(4094501) Cardiovascular stress test using bicycle ergometer

196

2016

0.95

0.26

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

157

0.81

0.26

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.66

0.25

1.4

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

324

3293

0.96

0.25

1.5

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

123

1137

1.06

0.25

1.7

1.8

4665.83

3784.65

u/l

0.12

459

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.24

0.25

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

185

1903

0.95

0.25

2.0

2.1

10.86

11.05

mg/l

0.13

170

1740

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.23

0.25

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

324

0.88

0.25

1.1

1.2

111.96

141.24

mmol/24h

2.30

324

(3021788) Differential panel - Synovial fluid

143

1481

0.95

0.25

1.6

1.5

—

(3036603) Volume of Urine

417

1.11

0.25

1.4

1640.83

1832.15

0.97

395

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.21

0.25

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

130

1.21

0.25

1.5

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

321

3260

0.96

0.25

1.1

1.04

1.53

u/ml

—

(3006462) Nitrate [Presence] in Urine

381

1.11

0.24

3.9

3.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

384

0.89

0.23

1.1

1.2

1.03

1.06

ratio

0.95

140

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

260

0.87

0.23

1.0

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

247

2518

0.96

0.23

1.9

1.4

3.06

2.97

g/l

0.66

211

2163

(3013707) Erythrocyte sedimentation rate by Westergren method

5753

56704

0.99

0.23

4.2

4.4

14.27

12.93

mm/h

9.57

5199

52160

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.27

0.23

2.9

3.0

—

39.64

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

342

0.89

0.23

1.0

0.61

0.47

u/ml

0.36

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.29

0.23

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

102

942

1.06

0.23

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

345

1.11

0.22

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

193

1975

0.96

0.22

1.9

1.6

13400.47

12393.86

e6/l

0.12

146

1421

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

122

0.80

0.22

1.1

111.70

112.59

—

116

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

178

1.16

0.22

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

178

1.16

0.22

2.5

—

(3023410) Appearance of Cerebral spinal fluid

639

1.08

0.22

1.8

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

169

1.16

0.21

31.2

32.5

7.52

7.00

ug/l

0.77

152

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.20

0.21

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.20

0.21

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(3008717) Parietal cell Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

535.00

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

6.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

1.45

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.21

0.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

174

0.85

0.21

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.17

0.21

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

298

0.89

0.21

1.3

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

308

0.89

0.20

1.1

1.3

145.39

134.12

nmol/l

0.53

308

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

163

0.84

0.20

1.0

1.1

3.19

10.92

u/ml

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.20

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.20

0.0

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.5

—

119.40

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.20

0.0

10.4

—

71.00

—

(3052592) Norovirus Ag [Presence] in Stool

131

0.82

0.20

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

250

2373

1.03

0.20

1.6

1.7

2.62

3.68

mg/l

1.95

184

1740

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

162

0.85

0.19

1.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

498

4780

1.02

0.19

2.1

1.5

—

(3024471) HLA-A [Type]

116

1.18

0.18

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.20

0.18

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

646

1.06

0.17

1.6

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

126

1.17

0.17

1.9

1.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

160

0.86

0.17

1.5

2.5

6.19

7.24

mmol/l

—

100

(3014765) Yersinia sp identified in Stool by Organism specific culture

234

2227

1.03

0.17

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

153

1560

0.96

0.17

1.3

224.60

216.35

miu/ml

0.10

735

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

390

1.08

0.17

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

397

3983

0.98

0.16

2.6

3.0

123.65

128.04

g/l

4.22

390

3880

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

2524

0.97

0.16

1.8

1.4

9.88

10.00

g/l

0.17

213

2157

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

277

1.10

0.16

1.1

97.43

757.53

ng/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

596

0.94

0.16

1.4

1.2

0.96

1.39

u/ml

0.25

326

(3036180) Methadone [Presence] in Urine

138

0.85

0.16

1.0

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

271

0.90

0.15

2.0

3.0

27.44

27.55

umol/l

0.02

205

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

335

1.08

0.15

1.5

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

154

1459

1.04

0.15

2.2

2.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

217

2069

1.03

0.15

2.9

1.5

41.11

29.96

mg/l

0.62

168

1674

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

240

0.90

0.15

1.1

—

(40768797) Stomach Pathology biopsy report

1100

10917

0.99

0.15

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

614

0.94

0.15

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

614

0.94

0.15

1.1

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

8110

79671

0.98

0.15

25.3

18.5

129.92

132.53

g/l

68.87

7980

78164

(3014051) Protein [Presence] in Urine by Test strip

226

2157

1.03

0.15

2.8

2.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.79

0.14

1.4

1.1

0.11

0.17

u/ml

—

(42529406) Shigella sp [Presence] in Stool by Culture

234

2236

1.03

0.14

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

528

5266

0.98

0.14

2.4

28.35

29.43

au/ml

0.08

366

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

922

1.04

0.14

1.2

3.52

3.91

u/ml

0.19

379

(40759836) Histone Ab [Presence] in Serum by Immunoblot

612

0.95

0.14

1.1

1.2

—

(3010813) Leukocytes [#/volume] in Blood

8109

79655

0.98

0.13

25.1

18.4

6.35

6.53

e9/l

9.01

7880

76720

(3020491) Glucose [Moles/volume] in Blood

490

0.94

0.13

1.4

2.0

6.03

6.93

mmol/l

3.30

335

(3045716) Anion gap in Serum or Plasma

300

1.08

0.13

3.4

2.4

9.35

9.66

mmol/l

0.25

294

(3005011) Chlamydia sp Ab [Titer] in Serum

107

0.83

0.13

1.9

1.8

—

(3026361) Erythrocytes [#/volume] in Blood

8110

79660

0.98

0.13

25.1

18.4

4.33

4.41

e12/l

57.46

7880

76742

(3014271) Vancomycin [Susceptibility]

415

1.06

0.12

3.1

3.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

201

1922

1.03

0.12

1.2

203.33

158.54

titre

0.19

151

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

149

1.12

0.12

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

916

1.04

0.12

1.2

1.1

5.42

3.99

u/ml

0.26

354

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

230

2205

1.02

0.12

1.1

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

217

2080

1.02

0.11

2.9

1.5

40.19

38.68

mg/l

0.09

165

1691

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

178

1.10

0.11

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

388

1.06

0.11

1.5

1.3

1.65

1.63

g/l

0.21

388

(3024731) MCV [Entitic volume]

8110

79652

0.99

0.11

25.1

18.3

91.65

91.16

20.80

7978

78129

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

195

0.91

0.11

1.2

1.4

74.95

89.76

ng/l

0.48

195

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

617

0.95

0.11

1.1

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

226

1.09

0.11

1.1

4.3

57.71

67.14

mg/l

0.42

141

(3011985) Renin [Units/volume] in Plasma

108

1025

1.03

0.11

1.4

66.55

52.01

mu/l

0.36

913

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

108

1025

1.03

0.11

1.2

—

nmol/l

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

616

0.96

0.10

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

616

0.96

0.10

1.1

1.2

—

(3035941) MCH [Entitic mass]

8110

79647

0.99

0.10

25.0

18.3

30.28

30.18

6.86

7978

78124

(3024932) HLA-DR beta [Type]

113

1.13

0.10

1.1

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

275

1.07

0.10

1.1

99.96

96.00

0.27

208

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.14

0.10

1.4

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4188

40968

1.01

0.10

2.7

—

(3047181) Lactate [Moles/volume] in Blood

197

1974

0.98

0.09

4.0

4.9

1.19

1.29

mmol/l

0.74

177

1728

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

142

1.11

0.09

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.02

0.09

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

305

1.06

0.09

1.5

17.11

15.77

pmol/l

0.72

255

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

171

1.09

0.09

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

238

1.07

0.09

2.6

2.0

51.19

51.81

umol/l

0.04

191

(3050794) Legionella sp Ab [Presence] in Serum

1.11

0.09

1.0

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.11

0.09

1.0

1.3

—

16.82

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

213

2129

0.98

0.08

1.9

1.4

37.56

37.77

g/l

0.20

177

1772

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

162

1.09

0.08

1.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

562

0.96

0.08

1.1

38.91

33.37

mmol/l

1.20

453

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.80

0.08

1.0

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

159

1593

0.98

0.08

2.9

3.1

1.58

1.53

mmol/l

0.17

159

1561

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

172

1.08

0.08

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

790

1.03

0.08

1.1

1.51

1.47

g/l

0.50

705

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

153

1.09

0.08

1.2

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

432

1.05

0.08

1.5

1.6

81.74

73.59

umol/l

0.40

432

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

301

2995

0.99

0.08

2.0

40.58

40.03

u/l

0.19

258

2631

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.12

0.08

1.0

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

201

0.93

0.07

1.3

1.4

32.36

39.19

0.34

138

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.83

0.07

1.3

25.78

10.21

pmol/l

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.83

0.07

2.0

1.9

1.23

1.66

mg/l

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.81

0.07

1.3

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

351

0.95

0.07

1.0

1.1

—

(3007461) Platelets [#/volume] in Blood

8109

79620

0.99

0.07

25.2

18.4

258.68

261.95

e9/l

4.54

7894

76998

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.06

0.07

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

918

1.03

0.07

2.2

2.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.85

0.07

1.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

157

1512

1.02

0.07

3.1

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

569

0.97

0.07

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

212

1.06

0.06

1.2

1.3

26.00

16.20

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

502

1.04

0.06

1.1

1.0

311.57

297.71

mg/l

0.77

449

(3004451) EKG impression Narrative

328

1.05

0.06

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

231

2239

1.01

0.05

2.1

1.5

0.66

0.38

g/l

0.81

187

1866

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

156

1.07

0.05

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

408

1.03

0.05

1.1

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

135

1345

0.98

0.05

1.7

328.02

331.82

mu/l

0.05

128

1201

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

137

1.07

0.05

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

137

1.07

0.05

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

204

1980

1.01

0.04

1.3

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

435

0.97

0.04

1.1

1.0

3.94

5.21

nmol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

185

1836

0.99

0.04

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

8110

79547

1.01

0.04

25.1

18.3

38.90

39.47

9.01

7650

73431

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

188

1825

1.01

0.04

2.0

1.4

0.00

g/l

0.18

166

1637

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

365

0.97

0.04

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

148

1.06

0.03

1.1

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

285

0.96

0.03

1.9

2.0

308.65

120.65

umol/l

0.82

161

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

207

2013

1.01

0.03

2.8

1.5

2.13

1.46

ratio

0.47

168

(3018572) Chloride [Moles/volume] in Blood

134

1330

0.99

0.03

4.6

5.6

105.22

104.46

mmol/l

1.19

123

1177

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

106

1054

0.99

0.03

1.2

—

(3042733) HLA Ab [Presence] in Serum

126

0.93

0.03

4.4

4.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

501

4894

1.00

0.03

1.8

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

851

1.01

0.03

1.1

—

(3039000) Anion gap in Blood

134

1329

0.99

0.03

4.5

5.6

10.37

11.15

mmol/l

2.35

123

1176

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

490

4788

1.00

0.02

1.3

68.58

54.43

au/ml

0.66

252

(3019309) Folate [Moles/volume] in Red Blood Cells

1560

15278

1.00

0.02

1.8

1.7

1145.40

1195.22

nmol/l

1.19

1104

11294

(3044290) Cell count panel - Cerebral spinal fluid

138

1367

0.99

0.02

1.5

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

589

0.98

0.02

1.5

1.3

152.00

522.71

titre

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

201

1960

1.01

0.02

1.9

1.4

0.02

0.01

g/l

0.35

178

1765

(3007930) Methemoglobin/Hemoglobin.total in Blood

267

2633

0.99

0.02

3.7

4.2

0.89

0.05

255

2452

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

351

0.98

0.01

1.1

1.0

—

(3045424) Erythrocytes [Presence] in Urine

133

1296

1.01

0.01

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

744

0.99

0.01

1.9

1.4

84279.49

121655.03

e6/l

0.21

497

(3034770) Mitochondria Ab [Titer] in Serum

199

1943

1.01

0.01

1.2

221.67

1018.48

titre

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

170

1.04

0.01

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

645

0.99

0.01

1.7

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

576

0.99

0.01

1.6

1.3

41.25

61.33

titre

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

184

1798

1.00

0.01

2.0

1.4

0.00

g/l

-0.00

164

1630

(3034426) Prothrombin time (PT)

192

0.97

0.00

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

218

2145

1.00

0.00

1.9

1.8

4.38

8.34

iu/l

0.50

797

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

271

2665

1.00

0.00

3.7

4.2

1.56

1.60

0.31

259

2485

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

172

1.03

0.00

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

441

1.00

0.00

1.3

1.4

4.45

5.50

u/l

1.68

370

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

144

1.02

0.00

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.03

0.00

1.1

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

196

1.00

0.00

1.0

1.2

199.50

320.98

pmol/l

1.53

130

(3032057) Clostridioides difficile [Presence] in Stool

179

0.99

0.00

2.1

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

104

1.04

0.00

1.0

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

630

1.00

0.00

2.3

2.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

280

1.02

0.00

6.2

4.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

107

1.01

0.00

2.1

3.0

0.82

0.80

u/field

0.02

107

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

346

0.99

0.00

2.6

2.4

2428.60

789.38

u/ml

0.49

338

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

135

1.02

0.00

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

313

1.00

0.00

1.2

58.33

60.41

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.85

-0.00

2.4

2.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.87

-0.00

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

246.87

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.89

-0.00

1.1

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.97

-0.00

1.7

2.7

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.05

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.89

-0.00

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.95

-0.00

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

1.00

-0.00

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.02

-0.00

6.0

4.6

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.95

-0.00

4.4

7.2

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_BREAST_ERNEG – Malignant neoplasm of breast, HER-negative

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of breast, HER-negative

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of breast, HER-negative (C3_BREAST_ERNEG)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints